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 INTRODUCTION 
 Medicine is an art of fundamental to the health survival of humanity. 
Siddha system of Medicine is unique and is perpetuating for centuries because of 
its merits. This system of medicine developed within the Dravidian culture, which 
is of pre-vedic period. It is a divine system of Medicine which speaks not only 
about Vingnanam but also about Meingnanam. Siddhars used herbs, metals, 
minerals and any organic material, available in the universe as a medicine, which 
shows their abundant knowledge in various branches of medicine. 
 
 According to Siddha concept, Disease is caused when the normal 
equilibrium of 3 humours [Vatham, Pitham and Kabam] is disturbed. The factors 
which affect this equilibrium are environment, climatic conditions, diet and 
physical activities. ‘‘KuzhanthaiMaruthuvam’’ is one among the glorious 
branches of Siddha system inside which is hidden an enormous treasure for a 
healthy society. 
 
 Here ‘‘SooliKanam’’ is specifically taken for the Dissertation Subject as it 
probably correlates with the Childhood Asthma, which is a respiratory disease 
encountered by a large population of children today and limits their daily 
activities. 
 
 The Trial Drug ‘‘BalakabahariMathirai’’ is chosen on the basis of 
classical attributes of respective ingredients according to the doctrine of 
Suvai(taste) , Gunam(property), Pirivu(metabolic changes after digestion) 
,Veeriam(potency) and Seigai(specific action which would pacify the vitiated 
humors in SooliKanam). 
 
 Therefore I expect this Sasthric Medicine to be safe and efficient 
in reducing the symptoms of SooliKanam and bring quick recovery. 
 
 
   AIM AND OBJECTIVES 
AIM 
 The principal aim of the present clinical study is to evaluate the efficacy of 
the Trial Drug ‘‘BalakabahariMathirai’’ in the treatment of SooliKanam without 
any side effects and to ensure a new approach in the diagnosis and treatment of 
disease. 
 
OBJECTIVES 
 The Main objective of the present study is to create awareness about the 
Siddha system and to highlight the efficacy of Siddha drugs among the public. 
 To explore the Etiology, Clinical Features, Diagnosis and Investigations of 
SooliKanam through various Siddha classical texts. 
 To know the extent of correlation of Etiopathogenesis, Signs and Symptoms 
of SooliKanam with BalakabahariMathirai. 
 To analyse the Biochemical, Pharmacological, Antimicrobial actions of the 
trial drug and its therapeutic phyto-constituents. 
 To educate the Patients and their Parents in terms of prevention of disease, 
diet, habits and the importance of Pranayama and Yogasanas. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 REVIEW OF SIDDHA LITERATURE  
fzk; 
 rpj;j kUj;JtKiwapy; Foe;ijfspd; Neha; fzpg;gpy; fzk; my;yJ 
fiz vd;gJ Kf;fpakhdjhFk;. 
,ay; :  
 “fzk;” vd;gJ ‘fh;g;gr;#L” vdf; $Wth;.  khe;jj;jpd; njhlh; 
NehNa fzkhFk;.  ,J Fotpf;F khe;j Neha; Vw;gl;L KOtJk; 
Fzkhfhky; clypy; ,Ue;Nj Kw;wptUk;. 
 ‘fhpKfdbia tho;j;jpf; fkythrdpiag; Nghw;wp 
   mhpa nre;jkpopdhNy afj;jpa Kdptd; nrhd;d  
 nghpa khtpahjpahd NgRkf; fizapd; Nwh\k;  
  njhpaNt Gtpapd; kPJ nrg;GNtd; rpe;ij itj;Nj.” 
 guuhrNrfuk; ghyNuhf epjhdk; 
fzk; - nghUs; tpsf;fk; 
 T.V. rhk;grptk; gps;is mfuhjp> jkpo;nkhop mfuhjp> fk;gh; - jkpo; 
mfuhjp Nghd;w E}y;fspy; ‘fzk;” vd;w thh;j;ijf;Fg; gpd;tUk; nghUs; 
$wg;gl;Ls;sJ. 
 ‘xU Neha;”> ‘FiwT”> ‘$l;lk;”> ‘jpul;rp” 
NkYk; ‘fiz” vd;gjid ‘mk;G” vdTk; nghUs; nfhs;syhk;.  
Nghh;f;fsj;jpy; mk;gpidj; njhLf;Fk;NghJ khh;igf; Fwpitj;Nj 
nrYj;JtJ Nghy; fiz NehapYk; Kjd;ikahf ghjpf;fg;gLk; clypd; 
gFjp khh;G vd;gjhy; ,e;Neha;f;F ,g;ngah; mike;jpUf;fyhk;.  vdNt 
fzk; vd;gjid jpul;rpahd gy FwpFzq;fs; nfhz;l khh;gpid 
Kjd;ikahf ghjpf;Fk; Neha;epiy vd mwpayhk;. 
Neha; tUk; top 
 tUk; topapid nghWj;J  - 2 tif 
 tajpid nghWj;J   - 1 tif 
I. tUk; topapid nghWj;J>  
 I. fh;g;gr; #L & 
 II.  khe;jj;jpd; njhlh; Neha;. 
 
 II. tajpid nghWj;J  - ghYk; NrhWk; cz;Zk; gUtk;  
 
fh;g;gr; #L : 
  ‘gpwe;jehs; gps;isf;Fj; jhNd ed;wha;  
  gpjhthNy gpzpAlypd; NkNy Njhd;Wk;  
     rpwe;jgpzp fzkhe;jk; fug;ghd; Njhlk;” 
 Foe;ij kUj;Jtk; ghythflk; 
 vdNt ,e;Neha; mff;fhuzq;fisg; gw;wpaJ vdTk;> ‘gpjhthNy 
gpzpAlypd; NkNy Njhd;Wk;” vd;gjhy; rpj;j kUj;Jtj;jpy; 
mff;fhuzq;fSf;F Kjw;fhuzk; ‘je;ij” vd;gJk; GydhfpwJ. 
 mJ vt;thnwdpy; je;ijapd; Rf;fpyNjhlk; jhapd; ehjj;Jld; 
fyg;GWfpd;wNghJ cz;lhFk; Neha; fzk; (m) fh;g;gr;#L vd 
mwpag;gLfpwJ. 
 
fytpapy; Vw;gLk; tpfw;gk; : 
 jhahdts; jiyf;F vz;nza; Nja;j;J Fspj;j gpd; czT cz;L> 
kaf;fk;> Nfhgk;> jhfk; Kjypatw;why; gLj;J cwq;fp mjd; fhuzkhf 
Nky; Nehf;Fq;fhy; kpFjpg;gl;L ,Uf;Fk; fhyj;jpy; GUl irNahfk; 
nra;jhYk;> Mltd; fhiyapy; gioaJ cz;lTld; type;J ngz;izg; 
Gzh;e;J> ntapypy; jphpe;jgpd; ,utpYk; ,uhTzT cz;l clNdAk; 
Gzh;e;jhYk;> moyhdJ fpsh;r;rpAw;W #L cz;lhFk;.   ,g;gbg;gl;l 
fhyj;jpy; jq;fp gpwf;Fk; Foe;ijf;F fh;g;gr;#L cz;lhfp> khe;jk; kw;Wk; 
fz Neha; Vw;glf; $Lk;. 
        ghythflk; - khe;jfzk; 
fU cw;gj;jpapy; thAf;fspd; gq;F 
 ‘tpsq;Ffpd;w mghdthA ntspapdpw;Fk; 
  tpe;JTld; gpuhzthA gpdq;f shFk; 
  fyq;Ffpd;w cjhddJ fUit tsh;f;Fk; 
  fUtjw;Fs; tpid%d;Wk; fyf;Fk; ghU” 
 vd;W A+fp Kdpth; $Wtjhy; mghdd; ntspapypUg;gjhfTk;> 
gpuhzthA tpe;JTld; cl;nry;YtjhfTk;> mJ jpuz;l ehjj;ijg; gy 
 gpd;dq;fshf;FtjhfTk;> fUit cjhdthA tsh;g;gjhfTk;> fUtpy; 
tpidfs; %d;Wk; Nrh;tjhfTk; czuyhk;. 
NkYk; gpuhzthA tpe;Jtpw;F capNuhl;lk; mspg;gjhy; gpuhzd; 
ghjpg;gilAk; NghJ fUthdJ Nghlzpf;fg;glhky; fUcw;gj;jpapy; FiwT 
Vw;gl;L> moy; Fw;wk; tsh;r;rp mile;J fUtsh;e;j gpd;Gk;> mf;Fw;wk; 
ehs;gl tsh;e;J fzj;jpd; FwpFzq;fisj; Njhw;Wtpf;fpd;wJ. 
‘cd;dpa fh;gf; Fopahk; ntspapNy 
 gd;dpa ehjk; gfh;e;j gpUjptp 
 td;dpAk; thAT khAWQ; Rf;fpyk; 
 kd;dpa rkdha; tsh;f;F KjfNk” 
 jpUke;jpuk; 
NkYk; 
‘ghd;ik vd;w tpe;jq;Nf CWk;NghJ  
 ghAklh td;dpNahL thAjhNd” 
 mfj;jpah; ty;yhjp ehbE}y; 
vdNt fUtpw;F tpe;JtpypUe;J thjk;> gpj;jk; vd ,uz;L jhJf;fSk;> 
cjfePh;> ehjk; ,tw;wpypUe;J fgKk; fpilf;fpd;wJ. 
 ‘ td;dpAk; that khAWQ; Rf;fpyk;” vd;W $wg;gLtjhy;> fUTWk; 
fhyj;jpy; thAthdJ tpe;Jit vLj;Jr; nry;Yk; vd;gJk;> td;dp vd;Dk; 
moy; mjid fhj;J epw;Fk; vd;gJk; Gydhfpd;wJ.  ,j;jPAk;> thATk; 
jd;dstpy; kpFjpg;gl;L fUitj; jhf;Fk; NghJ mJ fdypy; mbg;gl;l 
gpz;lkhf khwp> ‘fzk;” cz;lhfpwJ vd;gJ rpj;j kUj;Jtj;jpd; JzpT. 
fzk; Njhd;Wtjw;F jha; fhuzkhjy; 
‘IaJ $bw; nwd;why; mhpitah; Jaue; jd;dhy;  
 nra;agw; GdyUe;jp nrwpry Njhle; jd;dhy; 
 igau ty;F yhSk; grpAl dpUj;j yhYk; 
 Ja;aNjhh; Fotp fl;Ff; fzq;fSe; Njhd;W kd;Nw” 
 mNahj;jpjhrh; ghythflk;  
 Iak; jd;dstpy; kpFjy;  
 mhpitaUf;F (20 - 25 taJ epuk;gpa ngz;) Vw;gLk; Jauk;  
 ghY}l;Lk; ngz;fs; grpAldpUj;jy;  
  ryNjhlk; 
,f;fhuzq;fshy; mj;jhia mz;b thOk; Foe;ijapd; cly; 
ghjpf;fg;gl;L Foe;ijfSf;F fzNeha; Vw;gLfpwJ. 
 ,t;tpU E}y;fspd; $w;Wgb Rf;fpyj;Jld; moy;jhJ cs;sJ vd 
mwpayhk;.  ,t;thW Rf;fpyj;Jld; $ba moy;jhJ jd;dstpy; 
kpFjpgLtjhy; Rf;fpyj;jpy; tpfw;gk; Vw;gl;L fUtpd; moy;jhJ 
khWgLfpwJ.  ,jdhy; fUtpw;F #L mjpfkhfpwJ. ,jidNa 
‘fh;g;gr;#L” vdf; nfhs;syhk;. 
II. khe;jj;jpd; njhlh; NehNa fzkhFk; : 
 khe;j Neha; Vw;gl;L KOtJk; Fzkhfhky; clypy; ,Ue;Nj 
Kw;wptUk;. 
 ke;jk; vd;gJ cUt epiyapy; cly;epiyapy; ke;jk;> mjhtJ jhapd; 
czthjp gof;fq;fshy; Fw;wq;fs; NflilAk; NghJ Foe;ijfSf;F 
Njhd;Wk; NfhshWfs; khe;j Neha; MFk;. 
khe;jk; njhlh;e;J epiyg;gjhy;> 
 cztpd; rhuk; clw;fl;LfSf;F Nrh;tjpy; jilfs; Vw;gLfpwJ. 
 rhuk; nre;ePuhf khWk; jd;ik ghjpf;fg;gLfpwJ. 
 kw;w clw;fl;Lfs; Nghlzpf;fg;gLtjpy; ghjpg;G 
 clw;fl;Lfspd; td;ik FiwfpwJ. 
 fzj;jpd; FwpFzq;fs; Njhd;WfpwJ. 
II. tajpid nghWj;J : 
 fzk; Njhd;Wk; taJg;gw;wp gpd;tUk; thpfshy; mwpayhk;. 
 ‘vd;dNt fz%d;W tUle; njhl;Nl 
  Vohz;L kl;Lf;F kUf;Fq; fhyk;” 
 ghythflk; 
 vd;w ghlypdhy; %d;W Mz;L Kjy; VO Mz;L tiu tUk; Neha; 
vd;gij mwpayhk;. 
Neha; tUk; top : 
I. Foe;ij kUj;Jtk; (ghy thflk;) E}y; fzk; Njhd;Wtjw;fhd  
topfis gpd;tUkhW $WfpwJ. 
 ‘IaJ $bw; nwd;why; mhpitah; Jaue; jd;dhy;  
   nra;gw; GdyUe;jpr; nrwpry Njhle; jd;dhy;  
  igau ty;F yhSk; grpAl dpUe;j jhYk; 
  Ja;aNjhh; Fotp fl;Ff; fzq;fSe; Njhd;W kd;Nw”. 
      - Foe;ij kUj;Jtk; 
(g.vz;.192). 
nghUs ; : 
 IakhdJ jd;dstpy; ,Ue;J $LtjhYk;> mhpitah;f;F 
(mhpitah; vd;gJ ngz;fspd; gUtq;fspy; xd;whFk;) NeUk; Jauj;jhYk;> 
gy;NtW tifg;gl;l ePhpid gUFtjhy; cz;lhFk; ryNjhlj;jhYk;> 
grpAld; ,Uf;Fk; jhapd; ghiy cz;gjhYk;> Foe;ijfSf;F fzNeha; 
Njhd;Wk;. 
 
II. gpwE}y;fspy; $wg;gl;Ls;s Neha;tUk ; top: 
 Fk;gKdp ghythflk; vd;Dk; Vl;by; fzj;jpd; Neha; tUk; top gw;wp 
gpd;tUkhW $WfpwJ. 
‘juzpjdpNyAW NraUlYjdpNy tU fizNuhf tuyhW Nfs;  
 fdpTngW nfw;gkpy; nuzkJ #bdhy; NghfkJ kpF #bdhy;  
tputpDlNd gy Njhrkjpdhypdp jhapDl ghy; Nttpdhy;  
 tps;Sgytprkjhy; jPapDl fhq;ifaha; ,sntapY nfhs;syhYk; 
cuAkhfhukJ FiwAkjpdhypdp cz;Z ghy; Ngjkjpdhy;  
 cwkhfNt fLk; #LlNd cz;zyhy; Gspj;j tif cz;zyhYk; 
GiuNkTk; mjpf ngUk; fhutif jpd;gjhy; mj;jpaJ #L kpQ;rp 
 GfOhpa khkprk; fUfpaJ nuzNk tw;wpaJNt naOk;Gk;” 
 Fk;gKdp ghythflk; ghly; vz;-
451 (g.vz;.113).                       
 
nghUs; : 
 nfw;gk; jhpj;jpUf;Fk; rkaj;jpy; Gz; Vw;gLtjhYk;> czT 
kpFjpahf cl;nfhs;tjhYk;> jha;f;F Vw;gLk; Njhrq;fshYk;> jha;ghy; 
,Wfp fbdg;gl;L nfhs;tjhYk;> jha;f;F gy tplq;fs; Vw;gLtjhYk;> 
cly; #l;bdhYk;> ntapypy; jphptjhYk;> czT Fiwthf 
cl;nfhs;tjhYk;> cl;nfhs;Sk; ghypy; Vw;gLk; Ngjj;jpdhYk;> kpf #lhd 
 czit cl;nfhs;tjhYk; Gspj;j czT tiffis cz;zyhYk;> 
fhutif czTfis kpFjpahf nfhs;tjhYk;> fh;g;gigapd; #L 
kpFjpahfp fh;g;gj;jpy; cs;s kftpd; cly; nkype;J fzk; Njhd;Wk;. 
 jpUts;St ehadhh; ,aw;wpa etuj;jpd rpe;jhkzp-800 vd;Dk; 
E}ypy; gpd;tUkhW $wg;gLfpwJ. 
 ‘ghuhd nfw;gntl;il kPUk; gf;Ftj;jpy;  
  Ntuhd tpe;J ntsp gl;L Nahdp tpOe;j njd;whw; 
  fhuhd gpz;lq; fdypyb gl;Lf; fhe;jpapdhw;  
 $uha; fzRu nka;J nkd;Nwahd; $wpNdNk” 
 etuj;jpd rpe;jhkzp-800 
nghUs; : 
 nfw;gntl;il kPwpapUf;Fk; Neuj;jpy; fUTw;wpUf;Fk; jhAld; je;ij 
Nrh;tjhy; fUthdJ (gpz;lkhdJ) fdypy; mbgl;L fzk; tUfpwJ. 
 jd;te;jphp itj;jpak; vd;Dk; E}ypy; gpd;tUkhW $wg;gLfpwJ. 
 ‘rPhpa njhd;ik nra;j jPtpid je;ijahfg; 
  ghhpypg; gpwg;gpw; nra;j ghtNk jhajhfg;  
  Nghpa raf; Fkhud; tpwe;jpyh fpwkj;jg;Ng 
  fhhpa nrtpypj; jhaha; fzk; ngw tsUk; ehspy;” 
 jd;te;jphp itj;jpak;. 
nghUs; : 
 Kw;gpwtpapy; nra;j jPtpidfs; je;ijahfTk; ,g;gpwtpapy; nra;j 
jPtpidfs; jhahfTk; nfhz;L \af; Fkhudhfpa fzk; Njhd;WfpwJ> 
 ruNge;jpu itj;jpa Kiwfs; fh;g;gpzp ghyNuhf rpfpr;ir 
gpd;tUkhW $WfpwJ. 
 ‘Njhd;Wka;a gjhh;j;je; Njhag;gif 
  A+d;W jhfk; grpkpFe; Jw;wpby;  
  Vd;w Jd;gnky;yhk; te;J #o;jyhy;  
  Md;w Nra;f;Ff; fzq;fSkhFNk” 
 ruNge;jpu itj;jpaKiwfs;-fh;g;gpzp 
ghyNuhf rpfpr;ir (g.vz;. 57) 
 
 nghUs; :  
 kpFjpahff; fgj;ij tpUj;jp nra;af;$ba gjhh;j;jq;fis 
rhg;gpLtjpdhYk;> grpAk; mjpfkhf ,Uf;ifapy; jz;zPh; 
mUe;JtjpdhYk; gw;gy fzNuhfq;fs; Foe;ijfSf;F cz;lhFk;. 
 
Neha; Njhd;Wk; taJ : 
 fzk; Njhd;Wk; taJ gw;wp gy;NtW fUj;Jfs; cs;sd.  fzk; 
Foe;ijfs; ghYk; Fbj;J NrhWk; cz;Zk; gUtj;jpy; tUk; NehahFk;.  
,J Foe;ijapd; %d;whkhz;L Kjy; Vohkhz;L tiu tUk; Neha; 
vd;gij> 
 ‘vd;dNt fz %d;W tUle; njhl;Nl 
  Vohz;L kl;Lf;F kpUf;Fq; fhyk;’ 
 ghythflk;. 
 vd;Dk; nra;As; thpfshy; 
mwpayhk;. 
,ij jtpu> 
 guuhr Nrfuk; vDk; E}ypy; ghyNuhf epjhd glyj;jpy; fzk; 
Foe;ijfspd; 12 taJ tiuapYk; fhZk; Neha; vd $WfpwJ. 
mjhtJ 
 ‘vd;w Njhh; fiz flhKkpg;gb naOe;J nghq;fp 
  epd;w Ngh; gjpndl;L jhdpiwe;jpU khz;bd; Nkyha;f; 
  fd;wpa ghyh; nka;apw; gd;dpuz;lhz;L fhWk; 
  epd;wpL nkd;W Kd;dhzpfo;j;jpdd; Kdptdd;Nw” 
 guuhr Nrfuk; (ghyNuhf epjhdk;) 
 
 ghythflk; E}ypy; fPo;fhZkhW $wg;gLfpwJ. 
 ‘kyKQ; ryK kpfj; jPa;e;J khh;gpyjpf Ruq;fhAk; 
  kyKk; tapW kpf nthpAk; tskha; jiyA kpf kaq;Fk; 
  ryKk; tus; jP jhd; FiwAk; rz;lhsk; NghYl; Rukhk; 
  jyNk gd;dpuz;lhz;L kl;Lk; jdjha; tUcq; FzkpJNt” 
 ghythflk; 
 vdNt> fzkhdJ Foe;ij gpwe;jJ Kjy; 12 Mz;L tiu Njhd;Wk; Neha; 
vdTk; nfhs;syhk;. 
 
fzj;jpd; tiffs; : 
 gy E}y;fspy; gytiffspy; fzk; tifg;gLj;jg;gl;L ,Uf;fpwJ. 
 ghythflk; E}ypy; 24 tifahf $wg;gLfpwJ. 
 ‘fzq;fl;Ngh; tphpj;jiwaf; Nfs;ed; whff; 
   fdthj fzk;gpj;j fzq; Fsph;e;j  
  kzkhd Nrj;kfzk; gps;is fl;F 
  khe;jfzk; mjpw;gphpT Ie;jhk; ,g;ghy; 
  JzkhePh;f; fzk;gpuspf; fzK ey;y  
  #ypfzQ; Ropfz kfh fze;jhd; 
  Fzkhd CJfzk; tul;fze;jhd; 
  nfhjpg;Gfzk; tPf;ffzk; ,d;dq; NfNs 
 
  NfNs eP gpwf;fzKk; me;j fd;jd; 
  fzKk;ke; jhufzk; vhpf ze;jhd; 
   KNseP uhkfzk; Mkfz nkj;j  
  Kf;Ffzk; %yfzk; Nguh kj;jpd; 
  thNsrpq; fpNahbuj;j fzkhk; vy;yhk; 
  tUj;Jiuj;j jpUg/J ehd;F khff;  
  NfhNsJ ,itjhNd kUj;J E}ypd;  
  Fwpg;gwpe;jhh;f; fy;yhky; kw;Nwhh;f; NfNj” 
 ghythflk; 
1. tsp fzk; 13. tPf;ff; fzk; 
2. moy; fzk;  14. gpwf; fzk; 
3. Ia fzk;  15. me;jff; fzk;  
4. khe;j fzk;  16. ke;jhu fzk;  
5. ePh;f; fzk;  17. vhp fzk; 
6. gpuspf; fzk;  18. ePuhk fzk; 
7. #yp fzk;  19. Mk fzk;  
 8. Rop fzk;  20. Kf;F fzk;  
9. kfh fzk;  21. %y fzk; 
10. CJ fzk;  22. Nguhk fzk;  
11. tus; fzk;  23. uj;j fzk;  
12. nfhjpg;G fzk;  24. rpq;fp khe;j fzk; 
 
mNahj;jpjhrh; ghythflk; E}ypy; 24 tifahf $wg;gLfpwJ.     
mitfs; : 
1. tspfzk;      13. tPf;f fzk;  
2. mow;fzk;      14. gpwf;fzk;  
3. Ia fzk;      15. me;jf fzk;  
4. khe;j fzk;      16. ke;jhu fzk;  
5. ePh;f; fzk;      17. vhp fzk; 
6. gpuspf;fzk;      18. ePuhk fzk;  
7. #ypfzk;      19. Mkfzk;  
8. Ropfzk;      20. Kf;Ffzk; 
9. kfhfzk;      21. %yfzk;  
10. CJfzk;      22. Nguhk fzk;  
11. tus; fzk;      23. uj;j fzk;  
12. nfhjpg;G fzk;     24. rpq;fp khe;jfzk; 
  
Mtpaspf;Fk; mKj Kiwr; RUf;fk; - vDk; E}y; 23 tifahf $WfpwJ 
mitfs; : 
1. thj fzk;      13. tPf;f fzk;  
2. gpj;j fzk;      14. gpwf;fzk;  
3. rpNyj;Jk fzk;     15. Mkf;fzk;  
4. khe;j fzk;      16. twl;rp fzk;  
5. ePh;f;fzk;      17. Kf;Ffzk; 
6. gpusp fzk;      18. Nghh;f;fzk; 
7. #iyf; fzk;      19. ,uj;j fzk;  
8. Rop fzk;      20. er;R khe;j fzk;  
9. kfh fzk;      21. CJ khe;j fzk; 
 10. CJ fzk;      22. vhp fzk;  
11. twl;rp fzk;      23. ke;jhu fzk; 
12. nfhjpg;G fzk;                                
 
 ‘jhdhd Njiu fzk; Kf;F fze;jhd; 
 jdpahd %y fzk; Nghh; fze;jhd;  
 Cdhd uj;j fzk; tpl khe;j fzKk; 
 CJ khe;jf; fzkhk; khe;j fze;jhDk; 
 Nfhdhd ke;jhu fzKe; jhDk;  
 $uhd vhpfzkh kpUgj;J %d;Wk; 
 ghdhd fzq;fs; gd;dpuz;L kl;Lk; 
 ghyfh;f;F NeUnkd;W gfh;e;jjhNk” 
  Mtpaspf;Fk; mKj Kiwr; RUf;fk;. 
Mj;k ul;rhkph;jk; vDk; itj;jpa rhu rq;fpufk; vd;Dk; E}ypy; gpd;tUkhW 
$wg;gLfpwJ. 
 ‘ghug;gh fztFg;G gjpndl;lhFk; 
  ghbdhh; thjfzk; gpj;jfzNkhL 
 Neug;gh Nrj;kfzk; khe;jfzkpd;dk; 
  ePh;f;fzQ; #iyf;fzk; gpuspfze;jhd; 
 rhug;gh CJfzk; Ropfze;jhd; 
  rhh;thd khfzKk; tul;fze;jhd;  
 $ug;gh nfhjpg;Gfzk; gpwf;fze;jhd; 
  Fwpg;gwpthiaiae;J fzKkhNk” 
       - Mj;kul;rhkph;jk;. 
khe;j Kjph;e;J> 
1. thjfzk;     14.. tPf;ffzk; 
2. gpj;jfzk;     15. Mkf;fzk; 
3. Nrj;kfzk;    16. Njiuf;fzk; 
4. khe;jfzk;     17. Kf;Ffzk;   
5. ePh;f;fzk;     18. %yf;fzk; 
6. #iyf;fzk;    19. Nghh;f;fzk; 
7. gpuspf;fzk;     20. ,uj;jf;fzk;  
 8. CJfzk;     21. tp\khe;jfzk; 
9. Ropfzk;     22. CJkhe;jfzk; 
10. khfzk;     23. me;jf;fzk; 
11. tul;fzk;    24. ke;jhu fzk; 
12. nfhjpg;G fzk;   25. vhpfzk; 
13. gpwf;fzk; 
 vd fzq;fs; 25 tifg;gLk;. 
 
guuhr Nrfuk; vDk; E}ypy; fzj;jpd; tiffs; - 18 vd;W $WfpwJ.  
mjhtJ> 
‘cunkDq; fizfz; Kd;NdUiuj;jhtWiug;glf; Nfz;kpd; 
RunkDw; fizAnkhd;W J}q;Fkf; fizAnkhd;W 
eputpa %y kpuj;j ePq;fUk; tul;rp ntg;Gf;  
fUTW kdyd; tPq;fp $baNjhh; kQ;r zPyd; 
ePykhq; fizapNdL epd;wpL ntSg;G khFk; 
rhyNt rj;jp NkYe; jg;gpyh khe;j Nkfk; 
Nkyjhk; tpidfs; Nghy kpFe;jpLw; fopr;ry; fhrk; 
MykhhpUk nta;g;G khtpit gjpndl;lhNk”. 
        - guuhrNrfuk;. 
1. thjfiz    10. tPq;Ffiz  
2. gpj;jfiz    11. ntSg;Gfiz  
3. Ruf;fiz    12. rj;jp fiz  
4. mj;jpRufiz    13. ,uj;j fiz  
5. tul;fiz     14. %yf;fiz  
6. thyre;jpufiz   15. fUq;fiz 
7. kNfe;jpufiz    16. kQ;rl;fiz 
8. J}f;Ffiz     17. epyf;fiz 
9. mdw;fiz     18. ntg;Gfiz 
Fk;gKdp ghythflk; vDk; E}y; fzj;ij 18 tifahf $WfpwJ. 
‘khJ fdpNthbdp NfSk; nuhd;gjpy; NgU tifahdjp eP 
kUT RuNkhbdp J}q;Ffiz nuj;jKk; twl;irNahL ntg;G fizAk;  
NghjNkhL tPq;fYk; mdy;fiz khe;jKk; kQ;rSk; ePykJTk;  
 nghq;fpLk; rh;j;jpNahL uj;jKk; NkfKlNd thNye;jpud; thiy re;jpud;  
NkhJkpdp mj;jpapd; Ruf;fid kNfe;jpu cs;SNuhfk; ngahpitfs;  
KiwahfNt apit tifa njhd;W Nkyjha; <uhW taJ kl;Lk; 
NfhjfY ghyiu thijaJ nra;ANk FzNkhlT rjq;fs; 
$whfNtapdp NkyhYiuf;fpNwd; xt;nthd;Wk; Cd;wp mwpNa” 
 - Fk;gKdp ghythflk;. ghly; vz;.452 (gf;f vz;.114). 
mitfs;: 
1. Ruf;fiz    10 ePyf;fiz 
2. J}q;Ffiz     11. rj;jpf;fiz 
3. %ynuj;jf;fiz   12. nuj;jf;fiz 
4. twl;irf;fiz    13. Nkff;fiz 
5. ntg;Gfis    14. mj;jpr;Ruf;fiz 
6. mdy;fiz     15. thNye;jpuf;fiz 
7. tPq;Ffiz     16. thy re;jpuf; fiz 
8. khe;jf;fiz    17. kNfe;jpuf;fiz 
9. kQ;rs;fiz    18. cs;S Nuhff; fiz 
 
7. [Ptul;rhkph;jk; vDk; E}y; - 8 tifahf $WfpwJ. 
 1. #ypfzk;    5. kfhfzk; 
 2. Kf;Ffzk;   6. Ropfzk; 
 3. Mk fzk;    7. fopfzk; 
 4. Njiu fzk;    8. tus; fzk; 
8. gps;isg;gpzp thflk; vDk; E}y; 8 tifahf $WfpwJ. 
 1. tus; fzk;    5. kfhfzk; 
 2. %y fzk;    6. kyf;fzk; 
 3. rPjfzk;     7. Fz;lypa fzk;  
 4. ,jafzk;    8. ePh;fzk; 
jd;te;jphp itj;jpak; raNuhf epjhdk; vd;Dk; E}ypd; gb 7 tifahf 
$wg;gLfpwJ. 
mitfs;> 
 1. thy rak;    5. jgd rak; 
 2. tPu rak;     6. rak; 
  3. jUz rak;     
 4. fzpf rak;    7. Mh;jk; 
ruNge;jpu itj;jpa Kiwfs; fh;g;gpzp ghyNuhf rpfpr;ir vd;Dk; E}y; 
$Wk; tiffs; 
 1. ePh;f;fzk;    9. ke;jhuf; fzk; 
 2. twl;fzk; 
 3. vhpfzk;    10. me;jf fzk; 
 4. Ropfzk;    11. Rufzk; 
 5. %yfzk;    12. mf;fuf; fzk; 
 6. Kf;F fzk;   
 7. tp\fzk;    13. Fd;wpaf;fu fzk; 
 8. Mk fzk;    14. Cj fzk; 
     - vd fzj;jpd; tiffs; $wg;gl;Ls;sd 
fzj;jpd; nghJ FwpFzq;fs; : 
I. ghythflk; $Wk; FwpFzq;fs; : 
1. nghJthd FwpFzq;fs; : 
 Foe;ijfSf;F khe;jNeha; gyKiw te;J Kw;wpYk; Fzkilahky; 
,Ug;gjhy; ,e;Neha; cz;lhFk;. 
 moy; mjpfkhfp moy; jzptjw;F topapy;yhky; Foe;ijf;F 
mjpfkhd #L cz;lhfp cly; vg;nghOJk; #lhf fhzy;. 
 nrhy;y Kbahjgb gytpjkhd NtWghL cly;gpy; Vwgly;  
 fz;fspd; epwk; ,aw;if epwj;jpw;F khwp fhzg;gly;  
 fz; ntUz;L ghh;j;jy; 
 Kfj;jpy; rpwpJ tpah;it cz;lhjy;  
 Foe;ij jhia tplhky; gpbj;Jf; nfhs;Sk; 
 iffs;> fhy;fs;. Kfk; ,it fWj;jy; 
 if> fhy;> Kfk; rpyrkaj;jpy; vhpe;Jk; Fsph;e;Jk; ntJg;Gz;lhjy; 
 kaf;fKz;lhjy; 
II. Rthrhraj;ij gw;wpa FwpFzq;fs; : 
 Nky;%r;R 
 fh;fh; vd;Dk; xypAld; ,Uky;  
  nghWj;J nghWj;J Ruk; fha;jy;  
 njhz;il fk;kyhfg; Ngry;  
 mdy; tPRtJ Nghd;W cl;Ruk; fhzy; 
 khh;G $k;GNghy; vOk;gp fhzy; 
III. Mkhraj;ij gw;wpa FwpFzq;fs; : 
 eh Ntf;fhL 
 tha; cyh;jy;> eh tusy; 
 ePh; Ntl;if  
 tha; ehw;wk; 
 grpj;jP Fiwjy; 
 tapW Nehjy; 
 tapW cg;gy; 
 tapWk; kyj;JthuKk; kpf vhpjy;  
 fzRuj;jpy; kyk; cs;Ns jq;fptply; (kyr;rpf;fy;) 
 kyk; ntl;ilahjy; (nts;isepw kyk;) 
 ePh; RUq;fy; 
 tapW fopjy; 
 Ngjp 
  - kyk; vz;nza; frpTs;sjhf ,Uj;jy; 
  - kythapypUe;J vg;nghOJk; Cd; fOtpd ePhpd; epwj;ij  
   Nghd;W ePh; frpe;J nfhz;NlapUj;jy;. 
  - rpy Foe;ijfSf;F rPjkhfTk;> ,uj;jkhfTk;> rPjKk; 
,uj;jKk;     fye;Jk; Ngjpahjy;. 
  - rpy Foe;ijfSf;F nts;is epwj;Jld; jz;zPh; NtW kyk; 
     NtwhfTk; fopjy;. 
Kf;Fw;w NtWghLfs; : 
 thjk;> gpj;jk;> fgk; Mfpa %d;Wk; jd;dpiyapy; khw;wk; milAk; 
NghJ Neha; cz;lhfpwJ. 
 ‘eLq;fpaNjhh; gpj;jkJ Nfhgq;nfhz;L 
 ey;y thAit gw;wp aOj;jpf; nfhs;Sk;” 
        - ghythflk; 
  Kjypy; gpj;jNjhlk; ghjpg;gile;J (jd;dpiy tsh;r;rp milfpwJ) 
tspFw;wj;jpd; njhopiyAk; (Ntw;Wepiy tsh;r;rp mile;J) ghjpg;gjhf 
nfhs;syhk;.  ,jidNa> 
 ‘ke;jkyhJ thA tuhJ” 
 Njud; Nrfug;gh. 
vd;w ghlyhy; ke;jj;jpdhy; (gpj;jFw;wk; Nfliltjhy;) thA cz;lhFk; 
vd mwpayhk;.  NkYk;> 
 ‘IaJ $bw; nwd;why;” 
 ghythflk;  
 Iaf;Fw;wk; jd;dpiyapy; tsh;r;rp miljy; vd nghUs;gLk;. 
,jidNa> 
 ‘fgj;jpidad;wp fhrRthrk; fhzhJ” 
    Njiuah;-gpzpfspd; Kjw;fhuzk;. 
vd;w ghlyhy; fgf;Fw;wk; Nflilahky; fhrk;> Rthrk;> \ak; fhzhJ vd 
mwpayhk;. 
 vdNt> 
 gpj;j Fw;wk; Nflile;J thjj;ij gw;wp thjf;Fw;wKk; Nflile;J fg 
,Ug;gplkhd khh;G> jiy ,t;tplq;fis gw;Wtjhy; fgFw;wKk; jd;dpiy 
tsh;r;rp mile;J ‘fzNeha;” cz;lhfpwJ. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  fh;g;gr;#L       fzk;     khe;jk;       fzk; 
  Rf;fpy RNuhzpj Njhlk;   jhapd; czthjp nray;fspy;  
             khWghL 
       gpuhzd;     Kf;Fw;w khWghL 
              mghdd;     ghjpg;G        (Foe;ijfSf;F) 
             cjhdd; 
 moy; Fw;wk; tsh;r;rpailjy;                    tapw;wpy; Iak; kpFjp     
            (fpNyjfk; 
                          
               ghjpg;G) 
        fh;g;gr;#L Vw;gly;             jPf;Fw;wk; ghjpg;G 
              (mdw;gpj;jk; rhkf;fpdp ghjpg;G) 
 
Foe;ij gpwe;jJk; tsh;r;rpAw;w 
moyhdJ fgj;jpd; ,Ug;gplkhd       cjhdd; 
khh;igg;gw;Wjy;          mghdd;    ghjpg;G 
 
thAitg; gw;wp mOj;jy;    khe;jk;  Vw;gly; 
 
Iak; jd;dstpy; kpFjy;    khe;jk; njhlh;e;J epiyj;jy; 
 
fzj;jpd; FwpFzk; Njhd;Wjy;   gpuhzd;> mghdd;> tpahdd;> 
       cjhdd; 
       rkhdd; - ghjpg;G 
        
       Iak; jd;dstpy; kpFjy;  
        
       mfl;ilg; gw;wpa IaKk; 
            khh;igg; gw;wpa IaKk; fzj;jpd;  
                  FwpFzq;fisj;  
                         Njhw;Wtpf;fpd;wJ. 
 
 
 
 tpsf;fk; : 
1. fh;g;gr; #l;bdhy; Vw;gLk; Kf;Fw;w NtWghL 
  czthjp nray;> Kaw;rp> mf> Gw fhuzq;fspdhy; Vw;gLk; 
Rf;fpy RNuhzpj Njhlq;fshy;> tpe;JTld; cl;nry;Yk; gpuhzd;> 
ntspapypUe;J fhf;Fk; mghdd;> fUit tsh;f;Fk; cjhdd; Mfpa 
thAf;fs; ghjpg;gile;J moy; Fw;wk; kpFjpg;gl;L. fh;g;gr;#L Vw;gLfpd;wJ. 
 ,t;thW kpFjpg;gl;l moyhdJ> fgj;jpd; ,Ug;gplkhd khh;igg; gw;wp 
Iaj;ij tsh;r;rpAwr; nra;J fzj;jpd; FwpFzq;fisj; 
Njhw;Wtpf;fpd;wJ. 
2. khe;jk;  fzk; Kf;Fw;w NtWghL 
 jhapd; czthjp nray;fspy; khWghL Vw;gl;L> mj;jhia mz;b 
thOk; Foe;ijfSf;F Kf;Fw;wk; khWgl;L> tapw;wpy; Iak; ;kpFe;J 
fpNyjfk; ghjpg;gilfpd;wJ.   gpd;dh; moy; Fw;wk; ghjpg;G mile;J 
mdw;gpj;jk;> rkhf;fpdp ,it jd;dstpy; Fiwtjhy; tapw;wpy; Iak; 
kpFe;J grpapd;ik> czT cz;z ,ayhik> nrhpahik Mfpait 
Vw;gLfpd;wJ.  ,jdhy; cjhdd;> mghdd; ,it ghjpg;gile;J ke;j epiy 
Vw;gl;L khe;jk; Vw;gLfpd;wJ.  khe;jk; njhlh;e;J epiyj;jhy; jPf;Fw;wj;jpd; 
ghjpg;G thAitg; gw;wp mOj;jp gpuhzd;> mghdd;> tpahdd;> cjhdd;> 
rkhdd; Mfpa thAf;fs; ghjpg;gile;J fgkhdJ mjd; ,Ug;gplkhd 
khh;gpy; tsh;r;rpAw;W> thAtpd; ,aw;ifNahl;lj;ijj; jLf;fpwJ.  ,t;thW 
mfl;ilg; gw;wpa IaKk;> khh;ig gw;wpa IaKk; jd; mstpy; tsh;r;rpAw;W 
fzj;jpd; FwpFzq;fs; Njhd;Wfpd;wJ. 
 
 
 
 
 
 
 
 
 
 #ypf;fzk; - rpj;j kUj;Jt Fwpg;Gfs ; 
#ypf;fzf; FwpFzk; 
cz;lhQ; #ypf; fzq;Nfsha; 
 cw;w Rthr NknyOk;gpj;  
jz;lh ,Uky; kpf cz;lhk;  
 jd;ik neQ;R tha;kl;Lk; 
njhz;il ehT Nkte;J 
 NrhUk; nghUkp tapWg;Gk;  
tz;lhh; Kiyaq; FbahJ 
 tifaha; KfKk; ehWkd;Nw. 
       - ghythflk; 
nghUs; : 
 Nky; %r;Rz;lhjy;> 
 ,Uky; mjpfk; Vw;gLjy;> 
 neQ;R> tha;> njhz;il> ehf;F nte;J Gz;zhjy;> 
 tapw;Wg; nghUky; cz;lhjy;> 
 Foe;ij jha;g;ghy; cz;zhJ Kfj;jpy; ehw;wkbf;Fk; 
   gps;isg; gpzp kUj;Jtk; - II 
#ypf;fzk; (fh;g;gfzk;) - Fwp Fzk;  
neQ;Rtha; njhz;il ehT 
 NeUw nte;J Gz;zha;  
JQ;ry;jd; KiyAz; zhJ 
 RthrNk bUk Yz;lhk; 
jQ;rkha; tapW nghUkpj; 
 jha;Kiy Az;nzhl; lhJ 
fQ;riy KfKk; ehWk; 
 fz#ypf; fzkp jhNk. 
   (if.gp.98-173) 
 
 
 
 nghUs; : 
 Rthrk; mjpfkhf vOk;Gjy;> 
 ,Uky; mjpfkhf cz;lhjy;> 
 neQ;Rk; thAk; kpfTk; Fsph;e;jpUj;jy;> 
 njhz;il> ehf;F> nte;J Nrhh;tiljy;> 
 nghUky; Vw;gl;L tapW cg;gpf; nfhs;sy;> 
 Foe;ij jha;g;ghiy cz;zhik>Kfk; kpfTk; ehw;wkbj;jy; 
 
Kf;Fw;w ,ay;  
 rpj;j itj;jpa mbg;gil jj;Jtj;jpd;gb cly; ,aq;Ftjw;Fhpa 
caph;jhJf;fs; thjk;> gpj;jk;> fgk; vdf; $wg;gLk;.  ,k;%d;W rf;jpfSk; 
jk; mstpy; nrt;tNd nray;gLk; NghJ cly; jhJf;fs; Nehapd;wp 
,aq;Ffpd;wd.  ,it jk; epiykhwp nray;gLk;NghJ clypy; Neha; 
cz;lhf fhuzkhfpd;wd.  
thjk;: 
thjk; thOkplk; : 
 tspahdJ mghdd;> kyk;> ,lfiy> ce;jpapd; fPo; %yk; 
fhkf;nfhb> ,Lg;G> vYk;G> Njhy;> euk;Gf; $l;lk;> fPy;fs;> kaph;f;fhy;> Cd; 
vd;Dk; ,lq;fspy; tho;tjhFk;. 
tspapd; ,aw;ifg; gz;G 
 xOq;Fld; jhNjo; %r; Nrhq;fp ,aq;f  
 vOr;rpngw vg;gzpAkhw;w vOe;jphpa  
 Ntfk; Gyd;fSf;F Nktr; RWRWg;G 
 thfspf;Fk; khe;jh;f;F 
thA ,aw;if epiyapy; epd;W Cf;fKz;lhf;fy;> %r;Rtply;> thq;fy;> 
kdnkhop nka;fSf;F nraiyj;juy;> kyk; Kjypa gjpdhd;F tpiuTfis 
ntspg;gLj;jy;> VO clw;fl;Lfs; kw;Wk; Ik;nghwpfSf;F td;ik 
nfhLj;jy; Mfpa nray;fisg; GhpAk;. 
, / J xd;whapUg;gpDk; jd; ,lk;> njhopy; Kjypatw;why; gj;J 
tifg;gLk;. 
 
 thjk; nray; #ypfzj;jpy; 
fhzg;gLk; epiy 
gpuhzd;  %r;Rtply;> thq;fy; 
czit nrhpj;jy;. 
ghjpg;G (%r;Rtply;> thq;fypy; 
rpukk;) 
mghdd; kyryj;ij js;Sk; 
md;drhuj;ij 
Nrh;g;gpf;Fk;. 
ghjpg;G (kyr;rpf;fy;> 
cly;td;ik Fiwjy;) 
tpahdd;  cWg;Gfis ePl;l klf;f 
nra;Ak;> cly; rhuj;ij 
epug;gpj;J cliy fhf;Fk;. 
ghjpg;G (cly; Fd;Wjy;) 
rkhdd; kw;w thAf;fis kpQ;r 
nthl;lhky; klf;fpr; 
rhpg;gLj;Jk;. 
ghjpg;G (gpw thAf;fis 
fl;Lg;gLj;Jtjpy; rpukk;) 
cjhdd; Nky;Nehf;Fq;fhy; 
vdg;gLk; Ngr;Rf;F 
Kjw;fhuzk; Kaw;rp> 
kNdhjplk; cz;lhf;Fk;. 
ghjpg;G (,Uky;> the;jp> 
Nky;%r;R> Ngr;nrhyp Fiwjy;> 
clw;Nrhh;T) 
 
ehfd;  vy;yh fiyfisAk; 
fw;Fk;gb nra;Ak;> fz; 
,ikf;Fk;gb nra;Ak;> 
ey;y gz;Gfis 
ghLtpf;Fk;. 
ghjpg;G (gbj;jy;> tpisahly; 
Nghd;w nray;fis nra;a 
rpukk;) 
$h;kd; nfhl;lhtp tplg;gz;Zk;> 
fz;jpwf;f> %lnra;Ak;> 
fz;zPh; tpog;gz;Zk;. 
,ay;G 
fpUfud; ehtpw;frpT> ehrpapw; frpT> 
Jk;ky;> ,Uky;> grpia 
cz;lhf;Fk;. 
ghjpg;G (thapy; Nfhio Eiujy;> 
,Uky;> %f;FePh; gha;jy;> 
grpapd;ik) 
Njtjj;jd; Nrhk;gy;> Nfhgk;> J}q;fp 
vOk;NghJ mah;r;rp 
cz;lhFk;. 
ghjpg;G (rpy Ntis kpFe;j 
mrjp fhzy;) 
jdQ;nrad; ,we;Jtpbd; fhw;nwy;yhk; 
ntspg;gl;l gpd;dh; 
%d;whtJ ehspy; jiy  
ntbj;j gpd; jhd; NghFk;. 
- 
 
 gpj;jk:; 
gpj;jk; thOkplk; : 
 gpq;fiy> gpuhzthA> ePh;g;ig>   %yhf;fpdp> ,Ujak;> jiy> nfhg;Go;> 
ce;jp> ,iug;ig> tpah;it> ehtpY}Wfpd;w ePh;> nre;ePh;> rhuk;> fz;> Njhy; 
,t;tplq;fspy; thOk;. 
 
moypd; ,aw;ifg; gz;G : 
  grpjhfk; Xq;nfhspfz; ghh;itgz; lj;J 
   Urpnjhp rj;jp ntk;iktPuk; - crpj   
  kjp$h;j;j Gj;jptdg; gspj;Jf; fhf;Fk; 
   mjpfhhp ahq;fh doy; 
 moyhdJ> jd; ,aw;if epiyapy; epd;W nrhpg;gpj;jy;> ntk;ik> 
ghh;it> grp> ePh;Ntl;il> Rit> xsp> epidg;G> mwpT> td;ik> nkd;ik 
vd;git cz;lhf;Fk;. 
gpj;jk; nray; #ypfzj;jpy; 
fhzg;gLk; epiy 
mdw;gpj;jk; ePh;tbTs;s nghUs;fis 
tws nra;Ak;> czit 
nrhpf;Fk;. 
ghjpg;G (grpapd;ik nrhpahik) 
,uQ;rfgpj;jk; nre;ePiu kpFjpg;gLj;Jk; rpyNtis ghjpg;G (ghz;L) 
rhjfg;gpj;jk; mwpT> Gj;jpiaf; 
nfhz;L> tpUg;gkhd 
njhopiy epiwNtw;Wk;. 
ghjpg;G (md;whl Ntiyfis 
nra;tjpy; rpukk;) 
 
gpuhrfk; NjhYf;F xspia 
nfhLf;fpwJ. 
rpyNtis ghjpg;G (Njhypy; 
mhpg;G) 
MNyhrfk; fz;fspy; tho;e;J 
tbtj;ij mwpar; 
nra;Ak;. 
,ay;G. 
 
 
 
 
 
 fgk;: 
Iak; thOkplk; : 
 rkhdthA> RopKid> tpe;J> jiy> Mf;fpid> ehf;F> cz;zhf;F> 
nfhOg;G> kr;ir> FUjp> %f;F> khh;G> euk;G> vYk;G> %is> ngUq;Fly;> 
fz;> fPy;fs; ,it Iak; thOkplk;. 
Iaj;jpd; ,aw;ifg; gz;G :  
 jplkPA nkd;gpizg;Gj; jpz;ikAw;w ahg;Gk; 
  mlNyh; tOtOg;Gk; Mf;iff; - fplh;f;F 
 ntUthg; nghWikAk; Nkyhd fhg;ghk; 
  ngUikj;jh ikankdg; NgR. 
fgkhdJ typT> vd;G %l;LfSf;F td;ik> Mw;wy;> tOtOj;jd;ik> 
clYf;Fj; Jd;gk; NeUq;fhy; mQ;rhky; nghWj;Jf; nfhs;sy; Mfpa 
ngUikia cilaJ. 
fgk; nray; #ypfzj;jpy; 
fhzg;gLk; epiy 
mtyk;gfk; EiuaPuypy; ,Ue;J kw;w 
ehd;F Iaq;fl;L gw;Wf; 
Nfhlha; ,Uf;Fk;. 
ghjpg;G (%r;R tpl  rpukk;) 
fpNyjfk; ,iug;igapy; ,Ue;J 
czT ePh; Kjypatw;iw 
<ug;gLj;jp nrhpg;gpf;Fk;. 
ghjpg;G (nrhpahik) 
Nghjfk; ehtpdpd;W Ritia 
mwptpf;Fk;. 
rpyNtis ghjpg;G (Ruk;) 
jw;gfk; jiyapdpd;W ,U 
fz;fl;Fk; Fsph;r;rpiaj; 
jUk;. 
rpyNtis ghjpg;G (fz; 
rptj;jy;) 
re;jpfk;  fPy;fis xd;Nwhnlhd;W 
nghUj;jpj; jsu nra;Ak;. 
 
,ay;G 
 
 
 clw;fl;Lfs ; 
rhuk; : 
cliyAk; kdijAk; Cf;fKwr; nra;jy; #ypfzj;jpy; 
rhuk; ghjpg;giltjhy; clw;Nrhh;T> cly; Fd;wp fhzg;gly; 
Mfpait cs;sJ. 
nre;ePh; : 
mwpT> td;ik. xyp> nrUf;F> xsp ,itfis epiyf;fr; 
nra;tJ. 
Ropfzj;jpy; rpy Nehapdh;fl;F ntSg;G cs;sjhy; nre;ePh; 
ghjpf;fg;gLfpwJ. 
Cd; 
clypd; cUtj;ij mjd; njhopw;fpzq;f mikj;jYk; 
vd;ig tsh;j;jYkhFk;. 
,J Ropfzj;jpy; ngUk;ghYk; ghjpg;giltjpy;iy rpy 
Ntis ePz;l ehl;fshf Neha; epiy fhzg;gl;lhy; Cd; 
Fiwe;J cly; Fd;wp fhZk;. 
nfhOg;G 
xt;nthU cWg;Gk; jj;jk; nraiy ,aw;Wk; NghJ 
fbdkpd;wp ,aq;f mtw;wpw;F nea;g;Gg; gir Cl;b 
cjtpGhpfpwJ. 
ePz;l ehl;fshf Neha;epiy fhzg;gl;lhy; ghjpg;G. 
vd;G 
cliy xOq;Fgl epWj;jp itj;jy;> nkd;ikahd 
cWg;Gfisg; ghJfhj;jy;> cly; mirtpw;F mbg;gilaha; 
,Uj;jy; Mfpa nray;fis nra;Ak; ,J Ropfzj;jpy; 
,ay;ghfNt cs;sJ. 
;%is 
vd;Gf;Fs; epiwe;J mitfSf;F td;ikAk; nkd;ikAk; 
jUtJ. 
,J Ropfzj;jpy; ghjpg;G miltjpy;iy. 
 
ntz;zPh; 
RNuhzpjk; 
jd;idnahj;j cUtg;ngUf;fpw;F ,lkhfpa 
fUj;Njhw;wj;jpw;F Kjyha; epw;gJ. 
 
 
 ,e;j vO clw;whJf;fSk; jj;jk; ,aw;ifg; gz;NghL ,Ue;jhyd;wp 
mitfs; nra;Ak; njhopy; ed;F eilngwhJ. 
 gUtfhyq;fs; :  
1. fhh;fhyk;   : Mtzp> Gul;lhrp (August &   
       September) 
2. $jph;fhyk;   : Ig;grp> fhh;j;jpif (October &   
      November) 
3. Kd;gdpf;fhyk;   : khh;fop> ij (December & January) 
4. gpd;gdpfhyk;  : khrp> gq;Fdp (February & March) 
5. ,sNtdpy;fhyk;  :  rpj;jpiu> itfhrp (April & May) 
6. KJNtdpy;fhyk;  : Mdp> Mb (June & July) 
 
tsp Kjypa Fw;wq;fs;> jd;dpiy tsh;r;rp> Ntw;Wepiy tsh;r;rp 
jd;dpiyailAk; fhyk; 
Kf;Fw;wk; jd;dpiy 
tsh;r;rp 
Ntw;Wepiy 
tsh;r;rp 
jd;dpiy 
miljy; 
thjk;  KJNtdpy;  fhh;fhyk;  $jph;fhyk;  
gpj;jk;  fhh;fhyk;  $jph;fhyk;  Kd;gdpfhyk;  
fgk;  gpd;gdpf;fhyk;   ,sNtdpy; KJNtdpy; 
 
 #ypfzj;jpy; Kjypy; gpj;jNjhlk; ghjpg;gile;J jd;dpiy tsh;r;rp 
mile;J gpd;dh; tspFw;wk; Ntw;Wepiy tsh;r;rp mile;J mjd;gpd; 
fgkhdJ jd;dpiy tsh;r;rp mile;J #ypfzj;jpd; FwpFzq;fis 
Njhw;Wtpf;fpd;wJ. 
 
 gpj;jk; jd;dpiy tsh;r;rp milAk; fhyk;  - fhh;fhyk; 
 thjk; Ntw;Wepiy tsh;r;rp milAk; fhyk;  - fhh;fhyk; 
 fgk; jd;diy tsh;r;rp milAk; fhyk;  - gpd;gdpf;fhyk; 
 
 vdNt fhh;fhyk; Kjy; gpd;gdpf;fhyk;> tiuAs;s fhyk; Ropfzk; 
Njhd;Wtjw;Fhpa fhyq;fshFk; (August & February). 
 
 
 Itif epyq;fs; : 
 Itif epyq;fisg; gw;wp njhpe;J nfhs;tjpd; %yk; ,d;dpd;d 
epyq;fspy; trpf;f ,d;dpd;d Neha;fs; cz;lhFk; my;yJ ePq;Fk; 
vd;gijAk;> clYf;F ed;ik my;yJ jPikgaf;Fk; epyj;J ePh;fs; gw;wpAk; 
kUe;Jfis rhg;gpLtjw;F kw;Wk; nra;tjw;F rpwg;Gila epyk; gw;wpAk; 
mwpayhk;. 
Ie;jpidf; Fzk; :  
1.  FwpQ;rp 
(kiy rhh;e;j 
epyk;) 
,J Neha;fSf;F ,Ug;gplk;> ,e;epyj;jpy; 
tpisAk; nghUs;fSf;F td;ik cz;lhFk;.  
,uj;jk; cwpQ;Rk; Ruk;> tapw;wpy; Mikf;fl;b 
cz;lhFk;.  rpNyl;Lkk; jq;Fk;. 
2.  Ky;iy (fhL 
rhh;e;j ,lk;) 
ty;iy Neha;> thj Neha; cz;lhFk; 
3.  kUjk; (tay; 
rhh;e;j ,lk;) 
,e;epyj;jpy; tpisAk; mWRitg; nghUs;fis 
cz;lhy; thjk; Kjypa Kj;Njhl Neha;fis 
xopf;Fk; 
4.  nea;jy; (fly; 
rhh;e;j ,lk;) 
nfhLikahd thj Neha; cz;lhFk;.  nkype;j 
cliyg; gUf;fr;nra;Ak;.  <uiyg; ngUf;Fk;> 
Fly;thAit cz;lhf;Fk;. 
5.  ghiy (kzy; 
rhh;e;j ,lk;) 
thjk;> gpj;jk;> fgk; ,tw;why; tpisfpd;w 
gpzpfl;F ,Ug;gplk; 
 
 
 
 
 
 
 
 
 
 
 ‘gpzpawpKiwik”  -  vz; tifj; Njh;T 
 
 ‘gpzpawp Kiwik” vd;gJ cliyg; gpzpj;jyha Nehiaj; 
njhe;Jnfhs;Sfpw xOf;fk; vdg;gLk;. 
tpjpAk; xOf;fKk; : 
 ,J 
1. nghwpahw;Nwh;jy; 
2. Gydhywpjy; 
3. tpdhjy; 
 vd;Dk; tpjpfisAk; mtw;iwj; Jizahfg; gw;wp xOFk; 
xOf;fq;fisAk; Fwpf;Fk;.  #ypfzj;jpy;> Nehahspf;F fhZk; 
FwpFzq;fs; : 
1. nghwpahy; mwpjy; : 
 1.  %f;F  - %f;F ePh; gha;jy; 
 2. eh    - Nfhio tbjy; 
 3. fz;   - rpyNtis fz; rptj;jy;  
 4. Njhy;   - rpyNtis mhpg;G> jbg;G fhzy; 
 5. nrtp  - rpyNtis fhjpy; rPo; tbjy; 
2. Gydhy; mwpjy; : 
 1. ehw;wk;   - %f;fpy; rsp rt;T jbg;GWjy; fhuzkhf  
     rpy Ntis ehw;wkwpa ,ayhik 
 2. Rit  - ,dpg;G> rpyNtis Ruk; ,Ue;jhy; ifg;G 
 3. xsp  - ,ay;G 
 4. CW  - ntg;gk; 
 5. Xir  - ,ay;G 
tpdhjy; : 
 tpdhjy; vd;gJ Nfl;lwpjy; kUj;Jtd; jd;id Nehf;fp te;j 
gpzpAw;wtidg;gw;wp mwpa Ntz;batw;iw mwpe;Jk;. jd; nghwp 
Gyd;fshy; gpzpahsDila nghwp> Gyd; topaha; czh;tij 
gpzpAw;wtdplj;jpNyh my;yJ mth; ngw;Nwhh; Rw;wj;jhiuf; nfhz;Nlh> 
mtdJ ngah;> taJ> jpiz> FLk;g tuyhW> czT gof;ftof;fk;> 
 Ke;ija Nehapd; tuyhW> xt;thik tuyhW Nghd;wtw;iw mwpjiyg; 
gw;wpaJ MFk;. 
vz;tifj; Njh;Tfs; : 
 gpzpia mwpAk; top> kUj;Jt E}y; ty;Nyhh;fshy; vz; tifaha; 
tFf;fg;gl;Ls;sJ. 
 ‘ehbg;ghprk; ehepwk; nkhoptpop 
 kyk; %j;jpukpit kUj;JtuhAjk;” 
vz;tifj; Njh;Tfshtd 
 eh 
 epwk; 
 nkhop 
 tpop  
 kyk; 
 %j;jpuk; 
 ];ghprk; 
 ehb 
 
#ypfzj;jpy; - vz;tifj; Njh;Tfspd; epiy 
eh : 
 ,jpy; Ruf;Fk; vr;rpy;. epwk;> thapd; topaha; ntspg;gLk; Nfhioapd; 
epwk;> fdk;> Ngr;rpd; jd;ik ,tw;iw ftdpf;f Ntz;Lk;.                      
 #ypfzj;jpy; - Nfhio kQ;rs; my;yJ gr;ir kQ;rs; epwj;jpy; 
fhzg;gLk;. 
 Ngr;rpd; jd;ik jho;e;j Fuy; xypAld; fhzg;gLk;. 
epwk; : 
 Njhy;> cjL> gy;> efk;>> eh ,tw;wpd; epwk; ftdpf;fg;gl 
Ntz;Lk;. 
 #ypfzj;jpy; rpyNtis Njhy;> fz;> eh> efk; ,it ntSj;J 
fhzg;gLk;. 
nkhop : 
 thj Nehahspf;F rkxypAk; 
  gpj;j Nehahspf;F cah;e;j xypAk; 
 Ia Nehahspf;F ,d;dpir Nghd;w <dj;njhdpAk; ,Uf;Fk; 
 #ypfzj;jpy; %r;Rtpl rpukk; cs;sjhy; Ngr;nrhyp Fd;wpAk;> 
Fuy; xyp jho;e;Jk; ,Uf;Fk;. 
tpop : 
 ,jpy; fhZk; epwk;> xsp> rhWk;gPis> topAk; ePh; ,tw;iw 
ftdpf;f Ntz;Lk;. 
 #ypfzj;jpy; rpyNtis fz; rptj;jy; kw;Wk; fz; mhpg;G 
fhzg;gLk; 
kyk; : 
 ,jd; epwk;> Eiu> ,Wfy;> ,sfy; ,tw;iw ftdpf;f Ntz;Lk; 
#ypfzj;jpy; rpyNtis kyf;fl;L fhzg;gLk;. 
%j;jpuk; : 
 ,jd; epwk;> vil> kzk;> Eiu> vQ;ry; ,tw;iw ftdpf;f 
Ntz;Lk;. 
 #ypfzj;jpy; %j;jpukhdJ ntz;ik fye;j kQ;rs; 
epwj;JlDk; EiuAlDk; fhzg;gLk;. 
];ghprk; : 
 thj Nehahspf;F cly; rpwpJ ntg;gkha; ,Uf;Fk;. 
 gpj;j gpzpahsh;f;F cly; kpF ntg;gkhapUf;Fk;. 
 Ia Nehapdh;f;F cly; jl;gkhapUf;Fk;.  md;wpAk; tpah;it 
tpLtJkhapUf;Fk;. 
 #ypfzj;jpy; rpyNtis Ruk; ,Ue;jhy; kpF ntg;gkhfTk;> gpw 
Neuq;fspy; jl;gkhfTk; tpah;it tpLtJkhapUf;Fk;. 
ehb : 
  ce;jpjidg; gw;wp aPuysTk; Gz;zha; 
   xUf;fhNy Rthre;jh Dz;lh kpf;f  
  te;jRuk; Grpdhw; NghyNt fha;e;J 
   tUj;jkha;j; jpl;L Kl;lha; kaf;fq; fhZk; 
  ,e;j tif fzf;fha;r;r nyd;Nw ehSk; 
   ,ak;Gthh; Gtp kPJ E}y;ty; Nyhh;fs; 
       - ghythflk; 
 ce;jpjidg;gw;wp - gpj;jkhdJ tapw;iwg; gw;wp 
<uysTk; Gz;zha; - khh;T gFjpia ghjpf;Fk; 
 ,e;Neha; ngUk;ghYk; khe;j Nehapd; njhlh;r;rpahf tUfpd;wJ.  
khe;j Nehapy; gpujhdkhf ghjpf;fg;gLk; cWg;G tapW> gpj;jj;jpd; ,Ug;gplk; 
MFk;.  gpj;jk; jd; ,ay;gpypUe;J khWg;gl;L Ntw;Wepiy tsh;r;rp mile;J 
fgj;jpidAk; fgj;jpd; ,Ug;gplkhd khh;igAk; ghjpj;J IakhdJ %r;R 
cWg;Gfspd; cs;splq;fspy; milj;J nfhz;L fhw;iw ,aw;ifahfr; 
nry;y nthl;lhkw; jLj;J> Ropj;J thq;f nra;fpwJ. 
 vdpDk; ,f;fl;Liuahsh; Kad;W ghh;j;j tplj;jpy; gpj;jk;> fgk; 
jd;dpiy tsh;r;rpAw;Wk; thjk; Ntw;Wepiy tsh;r;rp mile;Jk;> fPo;f;fz;l 
ehbeilahdJ ghpNrhjpj;J czug;gl;lJ. 
1. thj fgk; 
2. gpj;j fgk; 
1. thjfg ehb :  
  ‘ghq;fhd thjj;jpy; Nrj;Jk ehbg;  
   ghprpj;jhy; jpkph;NT Kisr;r yhFk; 
  jPq;fhd ,UkYld; re;jp Njhlk; 
   Nrh;e;jtplk; ntb#iy ,Uj; Nuhfk;  
  thq;fhj <iske; jhu fhrk; 
   typAlNd GwtPr;R cs;tPr;R tPf;fk; 
  Xq;fhZQ; RuKlNd Rthrfhrk; 
   cz;lhFk; ntFNeha;f;F KWjp jhNd” 
         - (rjf ehb) 
2.gpj;j fgehb : 
  ‘gz;ghd gpj;jj;jpy; Nrj;Jk ehb 
   ghprpj;jh yj;jpRu kpisg;G <is..” 
        - (rjf ehb) 
ePh;f;Fwp : 
 ‘te;j ePh; fhpnail kzk; Eiu vQ;rnyd; 
 iwe;jpaYstit aiwFJ KiwNa” 
      - Neha; ehly; Kjy; ghfk; 
 ePhpy; epwk;> kzk;> Eiu> vil> vQ;ry; Mfpatw;iw Nehf;f Ntz;Lk;. 
 nea;f;Fwp : 
 Foe;ijfspd; ehbeil rhpahf fzpg;gjpy; rpukk; cs;sjhy;> 
nea;f;Fwp ghpNrhjid %yk; Nehahsh; vf;Fw;wj;jhy; ghjpf;fg;gl;Ls;shh; 
vd;gjid fzpf;fyhk;. 
 fz Nehahspapd; rpWePiu Nrhjid tl;bypy; Cw;wp> #hpa xsp 
kpFe;j ,lj;jpy; ePhpd; miyapy;yhjNghJ ey;nyz;nza;j;Jsp tpl;L 
ghh;f;fg;gl;lJ. 
 rpyhpy; MopNghy; (Nkhjpuk;) gutpAk; 
 rpyhpy; Kj;JNghy; epd;Wk; fhzg;gl;lJ. 
 NtW rpyhpy; muntd ePz;Lk; fhzg;gl;lJ. 
 ‘muntd ePz;bd; thjk; 
 Mo;pNghw; gutpd; gpj;jk; 
 Kj;njhj;J epw;fpd; nkhoptnjd; fgNk” 
 
kUj;Jt topKiwfs ; : 
1. Ntw;Wepiy tsh;r;rpaile;j gpj;jj;jpid jd;dpiyg;gLj;j 
Ntz;Lk;.  
2. jd;dpiy tsh;r;rpaile;j Iaj;jpid rkg;gLj;j Ntz;Lk; . 
3. gpj;jf; Fw;wj;jhy; ghjpg;gile;Js;s thjj;jpidAk; rhpg;gLj;j 
Ntz;Lk;. 
4. td;ik ,oe;j clw;fl;Lfis td;ik milar; nra;Ak;  
 
 
 
 
 
 
 
 
 
 
 
 REVIEW OF MODERN LITERATURE 
 
ANATOMY OF RESPIRATORY TRACT 
In humans, the respiratory tract is the part of the anatomy involved with the 
process of respiration. The respiratory tract is divided into the upper 
airways and lower airways. The upper airways or upper respiratory tract includes 
the nose and nasal passages, paranasal sinuses, the pharynx, and the portion of 
the larynx above the vocal cords. The lower airways or lower respiratory tract 
includes the portion of the larynx below the vocal 
cords, trachea, bronchi andbronchioles. The lungs can be included in the lower 
respiratory tract or as separate entity and include the respiratory 
bronchioles, alveolar ducts, alveolar sacs, and alveoli. 
 
RESPIRATORY TRACT 
   
    Upper respiratory tract Lower respiratory tract 
 Nose   Larynx below vocal cords 
 Nasal passages  Trachea 
 Paranasal sinuses  Bronchi 
 Pharynx  Bronchioles 
 Larynx above the vocal cords  Lungs 
     
The Upper Respiratory Tract 
The upper respiratory tract, can refer to the parts of the respiratory system lying 
above thesternal angle (outside of the thorax), above the glottis (vocal cords), or 
above the cricoid cartilage. The larynx is sometimes included in both the upper and 
lower airways.The larynx is also called the voice box and has the associated 
cartilage that produces sound. The tract consists of the nasal cavity and paranasal 
sinuses, the pharynx (nasopharynx,oropharynx and laryngopharynx) and 
sometimes includes the larynx. 
 
 The Lower Respiratory Tract 
The lower respiratory tract or lower airway is derived from the 
developing foregut and consists of the trachea, bronchi (primary, secondary and 
tertiary), bronchioles (including terminal and respiratory), 
and lungs (including alveoli). It also sometimes includes the larynx. 
Respiratory Tree  
The respiratory tree or tracheobronchial tree is a term also used to refer to 
the branching structure of airways supplying air to the lungs and includes the 
trachea, bronchi and bronchioles. 
The trachea is the largest tube in the respiratory tract and consists 
of tracheal rings of hyaline cartilage. It branches off into two bronchial tubes, a left 
and a right main bronchus. The bronchi branch off into smaller sections inside the 
lungs, called bronchioles. These bronchioles give rise to the air sacs in the lungs 
called the alveoli. 
The lungs are the largest organs in the lower respiratory tract. The lungs are 
suspended within the pleural cavity of the thorax. The pleurae are two thin 
membranes, one cell layer thick, which surrounds the lungs. The inner (visceral 
pleura) covers the lungs and the outer (parietal pleura) lines the inner surface of the 
chest wall. This membrane secretes a small amount of fluid, allowing the lungs to 
move freely within the pleural cavity while expanding and contracting during 
breathing. 
 
 
 
 
  
 
 
 
 The lungs are divided into different lobes. The right lung is larger in size 
than the left, because of the heart is being situated to the left of the midline. The 
right lung has three lobes - upper, middle, and lower (or superior, middle and 
inferior), and the left lung has two -upper and lower (or superior and inferior), and 
a small tongue-shaped portion of the upper lobe known as the lingula.  
Each lobe is further divided up into segments called bronchopulmonary 
segments. Each lung has a costal surface, which is adjacent to the ribcage; a 
diaphragmatic surface, which faces downward toward the diaphragm; and a 
mediastinal surface, which faces toward the center of the chest, and lies against the 
heart, great vessels, and the carina where the two mainstem bronchi branch off 
from the base of the trachea. 
Bronchi 
A bronchus, also known as a main or primary bronchus, is an airway in 
the respiratory tract that conducts air into the lungs. There is a right bronchus and a 
left bronchus and these bronchi branch into smaller secondary and tertiary bronchi 
which branch into smaller tubes, known as bronchioles. 
 The primary bronchi. The right and left primary branches are formed by the 
division of the trachea at the level of T4 vertebra just behind the sternal angle. The 
right bronchus is wider, shorter and more vertical than the left so right bronchus is 
the more common sites for an inhaled foreign  object to  become lodged.  
 
 
 
 
 
 
 
 Each tertiary bronchus conduct, air to and form a bronchopulmonary 
segment.  
 All conducting and respiratory passage ways distal to the primary bronchi 
are found with in the lungs.  
The primary Bronchi 
Secondary Bronchi(Lobar Bronchi) 
Tertiary Bronchi(Segmental Bronchi) 
Smaller Bronchi 
 Bronchioles 
The bronchioles or bronchioli are the passageways by which air passes 
through the nose or mouth to the alveoli (air sacs) of the lungs, in which branches 
no longer contain cartilage or glands in their submucosa. They are branches of 
the bronchi, and are part of the conducting zone of the respiratory system. The 
bronchioles divide further into smaller terminal bronchioles which are still in the 
conducting zone and these then divide into the smaller respiratory bronchioles 
which mark the beginning of the respiratory region. 
The primary bronchi, in each lung, which are the left and right bronchus, 
give rise tosecondary bronchi. These in turn give rise to tertiary bronchi (tertiary 
meaning third). The tertiary bronchi subdivide into the bronchioles. 
Terminal bronchioles 
The terminal bronchiole is the most distal segment of the conducting zone. 
It branches off the lesser bronchioles. Each of the terminal bronchioles divides to 
form respiratory bronchioles which contain a small number of alveoli. 
Respiratory bronchioles 
The respiratory bronchioles are the narrowest airways of the lungs, one 
fiftieth of an inch across.The bronchi divide many times before evolving into the 
bronchioles. The bronchioles deliver air to the exchange surfaces of the lungs.They 
are interrupted by alveoli which are thin walled evaginations. Alveolar ducts are 
distal continuations of the respiratory bronchioles. 
Peculiarities of respiratory tract in children  
 Chest wall is thin, elastic, yielding and intrinsic muscles are weak 
 Short thorax with the ribs running more horizontally 
 Increase in Antero posterior diameter of the chest with limited inspiration  
 Epiglottis is longer and projects back wards at a greater degree than in older 
children.  
 All these peculiarities tend to increase the risk of permanent deformity in 
the chest wall in the presence of recurrent or long standing respiratory distress. By 
above 8 years the chest assumes conical shape since the antero posterior diameter 
is less than transverse diameter and the ribs are placed in a slightly downward 
direction.  
 CHILDHOOD ASTHMA 
Definition: 
Asthma is a non- Communicable chronic lung disease, characterized by 
 Airway inflammation. 
 Airway obstruction mainly due to muscle spasm, associated with muscosal 
edema and stagnation of the mucus. 
 Airway hyper reactivity to macrobiologicals and irritants 
 Airway remodeling in  uncontrolled asthma. 
Etiopathogenesis: 
  The etiological factors can be classified as biological and irritants. 
Aero Biologicals Irritants 
Dust mites Tobacco smoke 
Cockroaches Cooking fuel smoke 
Pollens Mosquito coil smoke 
Fungi Sprays 
Pets- Saliva, urine Perfumes 
Viral infections  
Food  
 
Genetic Predisposition: 
  Genetic factors play a contributing  role in the Pathogenesis of 
asthma. Molecular genetic linkage studies indicate that the ‘ Atopic’ gene  
locus is on chromosome 11 and the genes for cytokines that are important 
components in the pathogenesis of asthma are encoded in chromosome 5. The 
alleric cytokines are IL 3,4,5,9,13 and granulocyte macrophage colony 
stimulating  factor.  All these are linked to inheritance of an increased IgE 
response and increased bronchial hyper responsiveness. 
Increased prevalence of asthma is noticed in  
 Urban  children 
 Rapid urbanization increasing prevalence in the semirural  areas 
compared  to rural 
  Children attending schools  in  heavy traffic areas especially from lower 
socio economic population. 
 Children living in poorly ventilated homes and single room dwelling 
huts. 
 Children living in houses with tobacco smoking persons. 
 Children living in  houses where cow  dung  cakes, agricultural waste 
and firewood are  used as cooking fuel. 
 During Diwali and similar festivals ( by 100%) due to increase in SO 2. 
 Children in the age group of less than  5 years 75% 
 Above  5 Years of age 25% 
Viral infections 
 The precipitating factor for an asthma attack is 40% 
 The incidence varies from 29% to 54% in both atopic and non-atopic   
individuals. 
 Respiratory syncytial virus and rhinoviruses are the predominant 
viruses triggering  asthma. 
Patho physiology: 
 The main features of asthma are 
 Airway Obstruction 
 Airway inflammation and hyper responsiveness 
Airway obstruction in asthma is caused by 
  Edema and inflammation of mucous memebrane lining the airways. 
 Excessive secretion of mucus, inflammatory cells and cellular debris. 
 Spasm of smooth muscles of bronchi 
Inhalation of allergen leads to two distinct phases 
- Early phase 
- Late phase 
 Early phase : (15-30min) 
Re-exposure to  antigen causes Cross linking of  these bound lgE  
molecules by allergen which leads to degranulation of mast cells and  
  
 
 
 
 release of mediators ( Histamine, Leukotreins,prostaglandins, 
Platelet  activating factor, Bradykinin) 
 
Effect  of   early Phase: 
 Again there is release of mediators.  This phase presents as clinical  
asthma. 
 Histamine causes itching, sneezing, and broncho constriction. 
 Prostaglandin causes vasodilatation and capsular permeability 
predisposing  to nasal congestion. 
 Leukotriens are potent broncho constrictors. 
            Bronchial hyper responsiveness and asthma: 
 Bronchial hyper responsiveness is attributed  to one or more of the 
following abnormalities. 
  Defect in the airway 
 Abnormal neural control of airways 
 Bronchial inflammation 
 
CLASSIFICATION OF ASTHMA 
Extrinsic asthma ( atopic): 
 Nearly  90% of childhood asthma is extrinsic asthma which is 
allergic asthma.   It is often associated with a personal and /or family history of 
allergic diseases such as rhinitis, urticaria and eczema. Poistive wheal and flare 
skin rections to intradermal injections of extracts of antigens and increased levels 
of IgE in serum. 
Intrinsic asthma ( non – atopic): 
 A  Significant segment of asthmatic population will present with 
negative family or personal history of allergy, negative skin test. They have normal 
serum levels of IgE. Therefore cannot be classified on the basis of defined 
immunologic mechanisms, 
  Many of  these will develop a typical symptom complex upon 
contracting an upper respiratory illness,after several  days the patient begins to 
develop paroxysms of  wheezing  and dyspnoea that can last for days to months. 
 
Asthma – three phenotypes 
 Transient Wheezer-onset <3yrs-then resolving 
 Persistent wheezer -<3yrs and persisting 
 Late onset-onset  of  wheeze between 3-6 yrs 
 
CLINICAL MANIFESTATIONS: 
 Cardinal sign: 
 The presences of usually diffuse, polyphonic, bilateral and 
particularly expiratory wheeze is the cardinal sign of Asthma. 
Most Common symptoms: 
  Intermittent dry cough 
 Expiratory wheeze 
 Shortness  of   breath 
 Chest tightness 
 Intermittent non-focal chest pain 
 Nocturnal cough 
 Dyspnoea 
 Limitation of daily physical  activity 
 General fatigue 
Associated symptoms: 
 Allergic rhinitis 
 Sneezing 
 Itching 
 Nasal  Congestion 
 Gastro esophageal reflux 
  Symptoms   of   severe  persistent asthma: 
 Acute  severe  attacks  on asthma  represent  the  progression of an attack of   
broncho spasm  to the point  where the patient is breathless at rest and has the 
singns of cardiac stress.  They may be extremely sudden onset, but more 
commonly build up over several hours or days. 
The following are the symptoms of severe persistent asthma: 
 Increasing breathlessness 
 Dificulty in talking 
 Anxiety to the stage of panic 
 Feeble   Breath sounds 
 Absence of  Wheeze ( Silent chest) 
 Profuse  sweating, Restless ness 
 Fatigue 
 Respiratory distress 
 Cardiac arrhythmias 
 Pulsusparadoxus 
 Cyanosis 
 Visible overinflated chest ( Barrel shaped) 
 Difficulty in feeding 
 Inability  to talk in words or sentences 
Diagnosis 
 The diagnosis of asthma is a clinical one. Hence detailed  clinical  
history taking, physical examination and additional informations regarding family 
history of Atopy,allergic  exposures, circadian variations and seasonal 
exacerbations should be carefully considered. 
Recent Advances 
 Recognition of unified  airway disease. 
 Recognition of chronic inflammatory disease concept 
 Appreciating the asthma phenotypes based on  inflammatory 
cells involved and mediators released by  eosinophils, 
 neturophils, T- lymphocytes and  vascular and endothelial 
cells. 
 The importance of environment control. 
Asthma, genomics & family helath histories. 
 It has been predicted that genomics will “ revolutionize” public 
health as we know it today. 
 
Gene  Expression &  the Environment 
 It is generally understood that a complex relationship exists  between  
gene  expressions and  environmental  interactions   in  respiratory  diseases. 
Goals of Genomics 
 Genetic linkages in studies that range from replicating one gene at a 
time to complex multi- variant studies conclude that over 25 asthma or allergy 
susceptible loci have been identified. 
Goals of these studies 
1) Indetify  Susceptible individuals. 
2) Intervence  before the oneset of  disease. 
3) Design drugs that are genospecific 
 The genotype effects at  these loci were modified by the environment such that the 
same genotype was associated  with protection from or risk  for a phenotype  
depending upon an early life exposure. 
Goals of childhood asthma  management 
 Maintain normal activity 
 Regular school attendance 
 Full participation in sports activities 
 Good Sleep 
 Prevent  chronic asthma symptoms 
 Keep away acute exacerbations 
 Maintain normal lung function 
 No/little  adverse effect of drugs 
 
  Management 
 The management of asthma includes 
 Education 
 Environment control 
 Pharmacotherapy 
 Regular follow –up 
The goal  of long term asthma   care is to keep the child subjectively and 
objectively healthy. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 A CORRELATIVE STUDY OF ETIOPATHOGENESIS AND 
SYMPTOMS OF SOOLI KANAM WITH CHILDHOOD ASTHMA 
 
Etiopathogenesis of kanam (fzk; Njhd;w fhuzq;fs;) 
khe;jj;ij njhlh;e;J fzk; Vw;gLjy; :  
 Foe;ijfSf;F khe;jNeha; gyKiw te;J mJ Kw;wpYk; 
Fzkilahky; clk;gpd; cs; gFjpapNyNa ,Ue;J Kw;wp ,Ug;gjhy; fzk; 
cz;lhFk;. 
       - ghythflk; 
 ‘md;dKk; ghYk; nea;Ak; 
  mOfpa goKe; Njq;fha; 
 gpd;idAk; fliy nty;yk;  
  nghpaNjhh; fjypg; gz;Lk; 
 jpd;DNkhh; fhye; jd;dpy; 
  jPnad ntJk;G khfpy;  
 xd;WW gps;isf; Fj;jhd; 
  cte;JNk khe;j Kz;lhk;” 
        - ghythflk; 
 Hence  from the above literature evidence,it is clear that the imbalance 
nutrition in Mother’s diet is a major and  significant cause for the development of 
Mantham in children. 
 Ingestion of certain foods like Cow’s milk, Pea nut, soya, egg and certain 
proteins may cause allergic reaction to the lactating mother with a rise in serum 
IgE.  The high levels of IgE in the lactating Mother is transmitted to the child 
leading to atopic diease in the child.  (Official journal of American Academy of 
Pediatrics) 
 Dietary influences in early life, shape the plasticity of the immune system 
and food sensitivity is an important factor in the development of allergy in the first 
1 – 2 years of life (D.Behera, Bronchial Asthma) 
  Food allergy is a group of disorder in which symptoms result from 
immunologic response to specific food antigen in children during 1 – 3 years of 
life.  (Nelson, Textbook of Pediatrics) 
This correlates with Siddha Literature evidence that Mantham is a “Palparuva Noi” 
occurring during 1-3 years of life.  (Balavagadam page -126) 
,jid> 
 ‘Mz;nlhd;iwj; njhl;Nl afy;%d;wh khz;lsTk; 
 jhz;LNk khe;jNeha; jhd;” 
     vd;W ghythfl E}ypy; $wg;gl;L cs;sJ. 
 
‘jhz;LNk khe;j Neha;” vd $wg;gLtjhy;> khe;j Neha; njhlh;e;J 
epiyj;jhy; ‘fzk;” Vw;gLk; (taJ 3-12) vd;gJ GydhfpwJ. 
 vdNt khe;j tiffspy; xd;whd ‘Rop khe;jk;” njhlh;e;J 
epiyj;jhy; mJ Kjph;e;J ‘Ropfzk;” cz;lhfpwJ vdTk; njhpfpwJ. 
fh;g;gr;#l;bdhy; fzk; Njhd;Wjy; 
 ‘njhifahd fzq;fs; vy;yhk; fh;g;gr;#L” 
       - mNahj;jpjhrh; ghythflk; 
 ‘Rf;fpyj;jpy; RNuhzpjq; fyf;Fkd;W 
 G+e;jpLk; tpahjp %d;Wk;” 
       -jd;te;jphp ehb 
 ‘kpfpDk; FiwapD Neha; nra;A E}Nyhh; 
 tspKjyh ntz;zpa %d;W” 
       - jpUts;Sth; 
 Nkw;fz;l Fwpg;Gfspd; %yk; fzk; fUtpNyNa Njhd;Wk; 
mff;fhuz Neha; vd;gJk;> Rf;fpy RNuhzpj FiwghLfshy; fh;g;gr;#L 
Vw;gLfpd;wJ vdTk; mwpayhk;. 
 Hence “Garba soodu” can be correlated with the concept of “Genetic basis 
of Atopic diseases” 
 The risk of allergic diseases in a child approaches 50% when one parent is 
allergic and 66% when both parent are allergic. 
  The genetic defects affecting one or more arms of immune system result in 
primary immune deficiencies and the affected child may not be able to contain the 
pathogen or develop immune response to prevent recurrence. 
(Nelson, Text book of Pediatrics Vol-2) 
 
 
PARALLEL ANALYSIS OF SYMPTIOMS OF SOOLI KANAM WITH 
THAT OF CHILDHOOD ASTHMA 
(GENERAL SIGNS AND SYMPTOMS) 
S.NO Siddha aspects Modern comparision 
1. Nky; %r;Rz;lhjy;  Prolonged expiration and 
expiratory wheeze 
2. ,Uky; mjpfk; Vw;gLjy;  Prolonged Cough 
3. neQ;R> tha;> njhz;il> ehf;F 
nte;J Gz;zhjy; 
Inflammatory changes due to 
chronic persistent cough and 
breathing difficulty 
4. tapw;Wg; nghUky; cz;lhjy; Abdominal bloating and 
discomfort due to mouth 
breathing.  Asthma itself able to 
induce Gastro intestinal symptoms 
such as abdominal distension due 
to aerophagia. 
5. Foe;ij jha;g;ghy; cz;zhJ Nasal congestion and breathing 
difficulty, interferes with feeding 
6. neQ;Rk; thAk; kpfTk; 
Fsph;e;jpUj;jy;  &  Kfj;jpy;  
ehw;wkbf;Fk; 
Cooling of the peripheries & 
halitosis form mouth. 
 
With the perspective of bringing out an effective therapy for Sooli kanam from 
siddha system of medicine, the author has undergone this dissertation work with  
 BALAKABAHARI  MATHIRAI  Since this is a Literature based medicine it is 
effective and safe for pediatric usage. 
 The dosage of medicine is   ½ to 1 tabelt (twice daily) and the adjuvant is 
honey 
Physician’s Duty : 
 Siddha Treatment is not only for complete healing but also for prevention 
and rejuvenation.  Poet Thiruvalluvar says that the duty of Physician as follows:  
 ‘Neha;ehb Neha; Kjy;ehb mJ jzpf;Fk; 
 tha;ehb tha;g;gr; nray;” 
 ‘cw;whd sTk; gpzpasTq; fhyKq;  
 fw;whd; fUjpr; nray;” 
       - jpUf;Fws;. 
 So it is essential for a physician to know the extent of the disease, its 
etiology, the nature of patients, severity of illness, seasons and time of occurrence 
and exacerbation. 
Line of treatment is as follows : 
1. Kaappu (prevention) 
2. Neekkam (Treatment) 
3. Niraivu (Restoration) 
1. Kaappu : (prevention) 
 Prevention is the main aim of siddha system.  Siddhars have described 
general preventive measures and special measures. 
 Especially in Balavagadam, special preventive measures that are said for 
prevention fo disease of the child starts from the time of conception in intra uterine 
life and also after delivery. 
 The Diet of pregnant wowen, Her habits, Specific medicine to be taken in 
each month of pregnancy, psychological conditions and surroundings influence the 
Prevention of disease in the expected child. 
2. Neekkam : (Treatment) 
 The aim of treatment is as follows: 
 To bring the vitiated three thoshams into normal equilibrium state. 
  To treat the patients according to the symptoms by internal medicine – 
Balakabhari Mathirai  
 To educate the Patients about the disease using Flash cards. 
 To teach them simple breathing Exercises which can be followed reqularly 
 at home. 
3. Niraivu : (Restoration) 
 Reassurance of disease recovery was given to all patients. 
 All the patients were advised to have a healthy lifestyle that provides a 
 disease free life.  
 Anxiety and general fear about the disease was discouraged by educating 
the  patients and their Parents. 
 All the patients were insisted for regular Follow up for the assessment of 
Prognosis which regained their confidence about disease recovery. 
i. Diet : 
 Siddhars advise the diet regimens for patients with Kanam.  They are 
explained below. 
fiz NehahspfSf;F MFk; fwp tptuk; : 
 ‘fz;L nfhs;thh; fwp tiff;F tptuk; NfS 
  fjpypAl fhahFk; KUq;ifg; gpQ;R 
 fz;L rpWfPiu neyypf;fha; jhdhFk; 
  jf;f Jtiu mtiuAl gpQ;RkhFk;  
 gz;L nea; ghy; fw;fz;L J}jsq;fha; MFk; 
  ghpthd KaYLk;gpd; ,iwr;rpahFk; 
 nfhz;Lld; nts;shL nts;nsypAk; 
  Fsj;jpYs;s tpuhy; krwpahNk “ 
       -kjiyNeha; njhFjp -II 
tpsf;fk; : 
 thiof;fha; 
 KUq;ifg;gpQ;R 
 rpWfPiu 
 ney;ypf;fha; 
  Jtiu 
 mtiug;gpQ;R 
 J}jsq;fha;  
 nea; 
 ghy;  
 fw;fz;L 
 Kay; ,iwr;rp 
 cLk;G ,iwr;rp  
 nts;shL  
 nts;nsyp 
 tpuhy; kPd; 
 krwp kPd; 
,it fiz Nehapdh;f;F MFk; czT gjhh;j;jq;fs; 
 
ii. Pathiyam : 
 During the course of treatment, the patients were advised to follow certain 
restrictions regarding  diet and physical activities. 
 This type of medical advice system termed as pathiyam.  Importance of 
pathiyam is said by Theraiyar as follows,  
 ‘gj;jpaj;jpdhNy gyDz;lhFk; kUe;J 
 gj;jpaq;fs; Nghdhy; gyd; NghFk; - gj;jpaj;jpy; 
 gj;jpaNk ntw;wpjUk; gz;bjh;f;F Mjypdhy; 
 gj;jpaNk cj;jpnad;W ghh;” 
 Njiuah; ntz;gh. 
 The patients with Sooli kanam were advised to avoid cool beverages, and to 
avoid exposure to chill weather and their specific allergens. 
PREVENTION METHODS : 
 The patients were advised 
 To findout the allergic causes and to stay away from them or tko have 
 Protective measures to avoid them. 
  To avoid contaminated food and water. 
 To take highly nutritious diet to develop their immunity. 
 Children who are able to under stand and follow the instructions are taught  
Simple Yogasanas and preventive measures.: 
 Pranayama and Yogasanas strengthen the muscles of respiration and 
diaphragm as well as regulate repiration.  Hence practising asanas is more helpful 
in asthmatic patients as supportive therapies. 
The following asanas are helpful in asthma 
 Pranayama 
 Bhujangasanam 
 Chakrasanam 
 Machasanam 
 Mayurasanam 
 Patha hasthasanam 
 Arai machayendhirasanam 
 Trikonasanam 
 Savasanam 
    -  Sirappu Maruthuvam 
The following are the simple yogasanas that were taught for the Patients :  
1. Pranayama 
2. Naadi suddhi 
3. Kapala bhati 
4. Bujhangasana 
Pranayama 
This consists of 
 Poorakam (to breathe in ) 
 Kubakam (To retain air) 
 Rechakam (To breathe out) 
Naadi sudhi : 
 This is the fundamental step of Pranayama which is referred to as alternate 
nostril breathing. 
 Kapalabhathi : 
 The technique of kapalabhati involves short and strong forceful exhalations 
(Rechakam) and inhalation (Poorakam) without kumbakam.  This facilitates free 
movement of muscles of stomach as well as those of diaphragm. 
 All these techniques of Pranayama have been found to increase oxygen 
consumption and alteration in metabolism and autonomic activities which are of 
therapeutic advantage.  (Shirlley telles et al., july 15 1993, yoga research paper 
svyasa). Therefore the efficiency of nervous system and cardiopulmonary system 
is increased and has been found to relieve the symptoms of Asthma. 
Bhujangasana : 
 This asana resembles as serpent posture with raised chest. 
 The benefits of Bhujangasana is it expands the chest, improves blood 
circulation and reduces fatigue and stress.                                      
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 MATERIALS AND METHODS 
 
SELECTION OF PATIENTS 
The present study covers both male and female children of paediatric age 
groups. All cases were carefully and thoroughly examined before admission. 
Those who fulfilled the criteria of SooliKanam according to the clinical features in 
siddha and modern reviews were selected with the aid of questionnaire. The 
opinion of faculties of department was obtained and detailed history was recorded 
in the proforma of case sheet. 
STUDY PARTICIPANTS 
INCLUSION CRITERIA:  
 
 Age : 3 – 12 years 
 Sex : Both male and female children. 
  Cough associated with Broncho-spasm. 
  Wheezing. 
  Tightness of chest. 
  Shortness of breath. 
   Mild fever. 
   Abdominal bloating associated with wheezing. 
   Loss of appetite. 
   Patients who are willing to stay in IPD Ward for 14 days or willingto 
attend OP Dept.  
 Children who are willing to undergo radiological investigationand give 
blood and urine samples for laboratory investigation. 
 Patient’s informant/ Parent willing to sign the informed consent stating that 
he/she will consciously stick to the treatment during 14days but can opt out 
of the trial of  his / her own conscious discretion.   
 
 
 
 EXCLUSION CRITERIA:  
 
 Children above 12 years. 
 Cough with haemoptysis. 
 High grade fever. 
 Wheeze other than respiratory cause. 
 Congenital heart disease / Cardiac asthma. 
 Dyspnoea associated with cyanosis and clubbing. 
 Abdominal distension due to any other serious illness. 
 Sudden reduction of weight. 
 Status Asthmaticus. 
 
WITHDRAWAL CRITERIA: 
 If any adverse reactions & altered symptoms occurred during the drug 
trial. 
 Intolerance to the drug.  
 Patient turned unwilling to continue in the course of clinical trial. 
 Occurrence of any serious illness. 
DIAGNOSIS 
 A case sheet was prepared on the basis of siddha and modern methodology 
to diagnose the disease and individual case sheet is maintained for each patient. 
 
1.Siddha diagnosis was made with the help of following methods 
Poriyalarithal 
Pulanalarithal 
Vinathal 
Ennavagaithervugal (Including neerkuri, neikuri) 
Udalthathukkal 
Paruvakaalam (Season) 
Thinaigal 
Mukkutram 
 
 2.LAB INVESTIGATIONS 
I.Blood 
 TC                                                   
 Differential WBC count 
 Neutrophils  
 Lymphocytes  
 Eosinophils 
 Monocytes  
 Basophils 
 Hb 
II.ESR 
 ½ hr&   1 hr 
 
III.Urine 
 Albumin 
 Sugar 
 Deposits 
SPECIFIC INVESTIGATIONS 
 
 X-RAY Chest PA View  
 Peak Expiratory Flow 
 Absolute Eosinophil Count 
 Specific IgE 
 Skin Sensitivity Test 
SELECTION OF DRUGS AND ITS ADMINISTRATION  
The trial drug is selected from,  
AgasthiyarVaithiyaPillaitamil.  
The trial medicine is BalakabahariMathirai. 
The trial drug was prepared carefully according to the siddha literature and 
given to all 40 patients twice a day and the dose is adjusted according to their age. 
 Drug Regimen  
BalakabahariMathirai,1/2 to 1 tablet with adjuvent honey twice a day after 
meals.  
The dosage of medicine with different age group 
3  to 7 years - ½ tablet 
8 to 12 years - 1 tablet 
 
DURATION OF TREATMENT 
   45 days 
 
ANALYSIS OF TRIAL MEDICINE 
 Biochemical analysis of the trial drugwas performed in the Department of 
Biochemistry , Government Sidhha Medical College, Palayamkottai. 
 Pharmacological analysis of the trial drug was carried out  at K.M.College 
of Pharmacy, Department of Pharmacology, Madurai.  
The Antimicrobial study was done at Malar Diagnostic Centre, Tirunelveli.   
  
CASE PROFORMA  
  The signs and symptoms of Soolikanam, history of present and past illness, 
personal history, nutritional history, family history, immunization history, 
laboratory investigations and managements were systematically recorded in 
proforma. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 DRUG REVIEW 
NAME OF THE MEDICINE: BALAKABAHARI MATHIRAI 
(INTERNAL) 
REFERENCE BOOK – AgasthiyarVaithiyaPillaitamil 
 
INGREDIENTS:  
 
S.N Name Botanical Name Parts used Quantity 
1 Adhimadhuram Glycyrrhizaglabra Root 5.25 gm 
2 Koshtam Costusspeciosus Root 5.25 gm 
3 Chukku Zingiberofficinale Rhizome 5.25 gm 
4 Milagu Piper nigrum Seed 5.25 gm 
5 ArisiThippili Piper longum Dried Fruit 5.25 gm 
6 Lavangapattai Cinnamomumverum Bark 5.25 gm 
7 LavangaPathiri Cinnamomumtamela Leaves  5.25 gm 
8 Sirunagapoo Mesuanagassarium Flower 5.25 gm 
9 Kadugurogini Picrorhizascrophulariiflora Root 5.25 gm 
10 Sitrarathai Alpinia galangal Root 5.25 gm 
11 Akkarakaram Anacyclus pyrethrum Stem 5.25 gm 
12 Velichapisin Gardenia resinifera Resin 5.25 gm 
13 Indhuppu Sodium Chloride Impura Salt 5.25 gm 
14 ThettranVithai Strychnospotatorum Seed 5.25 gm 
15 Adathodai Adhatodavasica Leaves 100 ml 
 
METHOD OF PURIFICATION 
 
       All drugs will be purified as per classical Siddha texts. 
 
 
 
 METHOD OF PREPARATION:  
  
 Raw drugs from item 1 to 13 are cleaned, purified, shade dried, roasted in a 
mild flame and then Powdered. They are sieved to get microfine powder and 
mixed homogeneously. Thettranvithai is made into small pieces and soaked in 
Adathodai leaf juice for 1 night. Then all the above ingredients are grinded with 
Adathodai leaf juice for 9 hours and made into fine tablets each weighing about 
0.6 gm (ThoothulangaiPramaanam).Finally  they are stored in cool and dry place. 
 
DRUG DOSAGE  
  
 According to age (1/2 to 1 tablet, twice daily)  
 
DRUG ADJUVENT  
  
 Honey 
 
INDICATION OF TRIAL MEDICINES: 
  
 Kabarohangal like Erumal, Kuthirumal, Kanarohangal and Eelairohangal. 
 
 
 
 
 
 
 
 
 
 
 
 1. t 
 
Botanical Name : Zingiberofficinalae 
Family  : Zingiberaceae 
பய}ப 
பாக  
: கிழu ( உலƫ|த¢ ) 
ண : ைவ - காƫ~©, த}ைம – ெவ~ப, பƬº – 
காƫ~©  
ெசைக  : ெவ~ப«zடாtகி    –Stimulant 
பசி{த{£z     -Stomachie 
அகyவாவகறி –Carminative  
ெபா¢ண  : “ைலம|த ெநxெசƬ~© ேதாடேம~ 
பமழைல 
 ¬ல இைர~ப¯ம ¬tநƫ – வாலகப  
 ேதாடமதி சார| ெதாடƫவாத }மநƫ{  
 ேதாடஆ மேபாtv t “ 
 
ெசƬயாைம, மாƫ© எƬvச, இைர~©, 
இ¯ம, கழிvச, நேரற, }ம, 
வய²~பச, ஐயர ேபா  
Constituents  : Analgesic, Sedative, Antipyretic   
Antibacterial 
properties  
: Sesquiterpenoids ( β -  sesquipnellandrene, bisabole 
and farnesene) 
Monoterpenoid fraction  ( β – phelladrene, 
cineolcitro)  
 
 
 
 
 
 
 
 2.kpsF 
 
Botanical Name : Piper nigrum 
Family  : Piperaceae 
பய}ப 
பாக  
: வைத  
ண : ைவ - ைக~©, காƫ~©, த}ைம – ெவ~ப; 
பƬº –காƫ~©   
ெசைக  : கார´zடாtகி     - Acrid 
அகyவாவகறி –Carminative  
«ைறெவ~பகறி  -Antiperiodic  
த~©zடாtகி     -Rubefacient 
ெவ~ப«zடாtகி  -Stimulant  
வ tகuகைரvசி    -Resolvent 
வாதமடtகி       -Antivatha 
நvசƬ            -Antidote  
ெபா¢ண  : “தயாக எu திƬ­மைத யாவ{¢  
ேமாயாம ெல~ப­ «zடாtகா – 
பாயா¢  
வள, த, கபtறuக இைவ 
அைன{த­ நt. அ}றி­ 
திமிƫவாத, கழைல, வள, சள 
இைவகைள­ அக²   
   (ேதர} ெவzபா)    
Constituents  : Piperine , Alkamides, Piptigrine, Wisanine, 
Dipiperamide, 50 – 60 % inhibitory activity on 
Acrtylcholinesterase 
 
 
  
3. mhprpj;jpg;gpyp 
Botanical Name : Piper longum 
Family  : Piperaceae 
பய}ப 
பாக  
: பழ 
ண  : ைவ -இன~©; த}ைம – தyப ; பƬº – 
இன~©  
ெசைக  : ெவ~ப«zடாtகி  - Stimulant 
அகyவா­அகறி –Carminative 
ெபா¢ண  : “ஈைள ய¯ம லிைர~©~ பசி~பனக 
மான ெவாழியாம வாyேம – 
யாள«ைற 
பாuகா யறி|¢ெசவ ƫ பzத{ைத~ 
பzதேர  
ேவuைகவா~ பா}கைண ெம” 
 
ஈைள, இ¯ம,இைர~©, உ~பச «தலிய 
பணகைள~ ேபாt. 
Constituents  : Piperine, Piperidine, Pipernonaline, 
Piperundecalidine 
 
 
 
 
 
 
 4.சிறர{ைத 
Botanical Name : Alpiniaofficinarum 
Family  : Zingiberaceae 
பய}ப 
பாக  
: ேவƫ  
ண : ைவ–காƫ~© ; வ Ƭய – ெவ~ப; பƬº – 
காƫ~©  
ெசைக  : ேகாைழயகறி - Expectorant 
ெவ~பகறி        - 
பசி{த{£z–Stomachic 
ெபா¢ண  :  தைலேநா, சதீள, இ¯ம, ர 
நu 
 சிறர{ைதைய வாயலிy ைவ{¢ 
வர  ெதாzைடய கy ேகாைழ, 
வா|தி, இ¯ம தண­ 
Constituents  : Flavonoids  
 
 
 
 
 
 
 
 
 
 
 
 5. அtகரகார  
 
Botanical Name : Anacyclus pyrethrum 
Family  : Asteraceae 
பய}ப 
பாக  
: ேவƫ  
ண : ைவ–காƫ~© ; த}ைம – ெவ~ப; பƬº – 
காƫ~©  
ெசைக  : ெவ~ப«zடாtகி – Stimulant  
உமிநƫெப¯tகி  -  
த~©zடாtகி       - Rubefacient 
ெபா¢ண  : நாவறyசி, ெதாzைடகம நu  
Constituents  : Anacyclin, Pellitorine, Hydrocarolin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6.mjpkJuk; 
 
Botanical Name   : Glycyrrhiza glabra 
Family    : Fabaceae 
Part used    : Nth; 
Fzk; : 
 Rit  : ,dpg;G>jd;ik- rPjk; 
 gphpT  : ,dpg;G 
nra;if:- 
 twl;rpafw;wp  Emollient 
 cs;soyhw;wp  Demulcent 
 Nfhioafw;wp  Mild Expectorant 
 kykpsf;fp   Laxative 
 cukhf;fp   Tonic 
 
nghJFzk; 
 fj;jpahp  Kg;gpzahy; tUGz; jhfq; 
  fz;Nzha;cd; khjk;tpf;fy; typntz; Fl;lk; 
 gpj;jnkYk; GUf;fp fphpr;ruk; Mth;j;j 
  gpj;jkj %h;r;ir tplghfk; ntg;ge; 
 jj;jptU thjNrh zpjq;fh khiy 
  rUttplq; fhkpaNeha; jhJ el;lq; 
 Fj;jpUky; Mrpaq;fk; ,jo;Neha; ,e;J 
  Fag;GZk;Nghk; kJhfnkdf; $Wq; fhNy 
          ( Nj.F) 
Constitunents:- 
 
    Glycyrrhizin 
   Glycyrrhetinic acid 
   Glycyrrhizinic acid 
 
 7. Nfh\;lk; 
 
Botanical Name   : Costus speciosus 
Family    : Costaceae 
gad;gLk; ghfk;   : Nth; 
Fzk;:- 
  Rit   :  ifg;G> tpWtpWg;G 
  jd;ik  : ntg;gk; 
  gphpT   : fhh;g;G 
nra;if:-  
grpj;jPJhz;b   Stomachic 
Nfhioafw;wp   Expectorant 
cukhf;fp    Tonic 
ntg;gKz;lhf;fp   Stimulant 
tpah;itg;ngUf;fp  Diphoretic 
nghJFzk;:- 
 ehl;bY  ntl;il eLf;fk; vDNeha;fs; 
 Nfhl;lnkdr; nrhd;dhy; fiyAq;fhz; - $l;bw; 
 RuNjhle; njhz;ilNeha; Njhyhj gpj;jk; 
 guNjrk;  NghNk gwe;J. 
 
8. ,ytq;fg;gl;il 
Botanical Name  : Cinnamomum verum 
Family   : Lauraceae 
gad;gLk; ghfk;  : gl;il 
Fzk;: 
 Rit   : fhuKk;  ,dpg;GKilaJ 
 jd;ik  : jl;gk; ( ntg;g tPhpa nkd;Wk; $Wth;) 
 gphpT   : ,dpg;G ( fhhg;ngd;Wq;$Wth;) 
nra;if:- 
ntg;gKz;lhf;fp  : Stimulant 
 mfl;Ltha;tfw;wp : Carminative 
fhkk;ngUf;fp  : Aphrodisiac 
nghJFzk;:- 
 jhJel;lk;  Ngjp rUttp\k; MfpaNeha; 
 G+jpfpu  fQ;rpye;jpg; G+r;rptplQ; - rhjptplk; 
 Ml;Lkpiug; NghbUky; MfpaNeha;f; $l;lkw 
 Xl;Lkpy tq;fj;  Jhp 
 rd;dytq; fg;gl;il jhd;Fsph;r;rp  Az;lhf;Fk; 
 ,d;Dkpuj; jf;fLg;ig  aPh;f;Fq;fhd -  Kd;dKWk; 
 ce;jpf; fLg;gfw;Wk; cz;%yg; Gz;Nghf;Fk; 
 fe;jkpF G+q;FoNy fhz; 
          (m.F) 
 
Constituents:- 
   Cinnamic Acid 
   Tannin 
 
9. ,ytq;fg;gj;jphp 
 
 Botanical Name   : Cinnamomum  tamala 
Family    : LAURACEAE 
gad;gLk; ghfk;   : ,iy 
Fzk;:- 
 Rit    : fhh;g;G 
 tPhpak;   : ntg;gk; 
 gphpT    : fhh;g;G 
nra;if:- 
 ntg;gKz;lhf;fp   Stimulant 
 mfl;Ltha;ftw;wp Carminative 
 grpj;jPJhz;b  Stomachic 
 tpah;itg;ngUf;fp Diaphoretic 
 nghJFzk;:- 
 NkfRuk; rPjRuk; ntl;ilRth rq;fhrk; 
 jhfgpj;jk;  the;jprh; thrpaNeha; - Nkfj;jpd; 
 fl;bnahL jhJjl;lq;  ifg;gUfp Nghf;fptpLk; 
 ,l;l ,y tq;fj; jpiy 
         ( m.F) 
 
Constiuents:-  
 Eugenol, Beta- Caryophyllene 
 Linalool, Caryhyllene  oxide 
 
 
10. rpWehfg;G+ 
Botanical Name   : Mesua nagassarium 
Family    : Calophyllacea 
gad;gLk;  ghfk;   : G+ 
Fzk;:-  
Rit     :  rpWifg;G.Jth;g;G 
jd;ik    : jl;gk; 
gphpT     : fhh;g;G 
nra;if:- 
    G+ 
Jth;g;gp   - Astringent 
mfl;Ltha;fw;wp  - Carminative 
nghJFzk;:- 
 rpWehfg; G+tpdJ nra;ifjidr; nrhy;Nthk; 
 FwpahFk; Nkfj;ijf; nfhy;Yk; - newptpl;Lj; 
 jPjha;r; nry;thAitAe; jPh;f;FkpF kwNghf;Fk; 
 Nfhjha; ,ijawpe;J  nfhs; 
Constituents:- 
  Mesuol 
 11. fLFNuhfpdp 
Botanical Name  : Picrorhiza scrophulariiflora 
Family   : Scrophulariaceae 
gad;gLk; ghfk;  : Nth; 
Fzk;:- 
Rit    : ifg;G> fhh;g;G 
jd;ik   : ntg;gk; 
gphpT    : fhh;g;G 
nra;if:-  
Kiwntg;gfw;wp   Antiperiodic 
ngUq;fopr;rYz;lhf;fp Cathartic 
grpj;jPj;Jhz;b   Stomachic 
Flw;GOtfw;wp    Anthelmintic 
nghJFzk; 
 khe;jr;  Ruikak; thAfug; ghkhkQ; 
 Nrh;j;jkyf; fl;L jphpNjhlk; - Nghj;jnghl;Lg; 
 Gd;tapW  Neha;itg;Nghk;  nghw;nfhbNa -  NgjpAz;lhk; 
 jpz;fLF Nuhfzpf;Fj; Njh; 
Constituents:- 
  Picrorhizin 
  Kutkin 
12. Njw;whd; 
Botanical  Name  : Strychnos  Potatorum 
Family   : Loganiaceae 
gad;gLk;  ghfk;  : tpij 
Fzk; :-  
Rit    : ifg;G 
jd;ik   : ntg;gk; 
gphpT    : fhh;g;G 
nra;if:- 
clw;Nww;wp   Alterative 
 cukhf;fp   Tonic 
grpj;jPj;Jhz;b  Stomachic 
cs;soyhw;wp  Demulcent 
rpWNfhioafw;wp  Mild Expetorant 
nghJFzk;:- 
 Njw;whd; fdp jdf;fr;  NrapioNt td;fhfj; 
 Njhw;wh njhopAQ; RthrKk;NghQ; -  rhw;wpd;kpf 
 the;jp ngUfk; kyk; Nghk;Kj; Njhlj;ijr; 
 Nrh;e;jgpzpfSk; NghQ; nrg;G 
         ( m.F) 
Constiuents:- 
 Brucine 
13. MlhNjhil 
Botoanical  Name   : Adhatoda vasica 
Family    : Acanthaceae 
gad;gLk; ghfk;   : ,iy 
Fzk;:- 
Rit     :  ifg;G 
jd;ik    :  ntg;gk; 
gphpT     : fhh;g;G 
nra;if:- 
,rptfw;wp    Antispasmodic 
Nfhioafw;wp   Expectorant 
El;GOf;nfhy;yp   Germicide 
rpWePh; ngUf;fp   Diuretic 
nghJFzk;:- 
MlhNjhilapd;  Fzj;ij milTl Diuf;ff; NfSk; 
ghlhj ehTk; ghLk; gphpe;JNk Njhlk; NghFk; 
thlhj gpj;jQ; Nrj;k Nuhfq;fs; tpyfpg; NghFk; 
ehlhJ tpahjp jhDk; ey;tpopf; FoypdhNs 
        (v.L) 
 Constituents:-  
   Vasicine 
   Adhatodic acid 
14.ntspr;r gprpd; 
Botanical Name  :  Gardenia resinifera 
Family   : Rubiaceae 
Part Used    : Resin 
Action   : Emetic 
     Antispasmodic 
     Expectorant 
     Carminative 
     Stimulant 
Chemical compound: Crocetin 
 
15.,e;Jg;G   : 
Cemical Name  : Sodium chloride impure 
English Name  : Rock Salt 
Rj;jpKiw   : ,jid fhbapd; %d;W ehs; Cwg;Nghl;L  
     #hpa xspapy; cyh;j;jp vLf;f Rj;jpahFk; 
 
nra;if 
 kyfhhp  
 mfl;L tha;tfw;wp 
 rpWePh; ngUf;fp 
 grpj;jPj;J}z;b 
 
nghJFzk; 
 ml;lFz;kk; ke;jk; mrph;f; fuQ;#h; rPj gpj;je;  
 Jl;litak; ehbg;Gz; Nlhlq;fs; - nfl;lkyf; 
 fl;Ltpl tpe;ijaf; fhkpaNeha; td;fug;ghd; 
 tpe;Jg;ig   tps;  
 ,e;Jg;gpdhy; vz;tpjFd;kk;> myrk;> mrph;f;fuk;> euk;G fpue;jp> ky ge;jk;> 
jiy> Nahdp Neha;fs;> Rthrk;> ,uj;j%yk; Kjypa gpzpfs; ePq;Fk; 
 
ேத}: 
ண : ைவ– இன~© ; நிற – இளமxச  
ெசைக  : உளழலாறி       
ேகாைழயகறி      
மலமிளtகி 
¢வƫ~ப  
அ¸கலகறி 
ேபாஷணகாƬ 
பசி{த{£z 
£tக«zடாtகி 
- Demulcent  
- Expectorant 
- Laxative 
- Astringent 
- Antiseptic  
- Tonic 
- Stomachic  
- Hypnotic 
ெபா¢ண
  
: அவத பலிtக ேவzமானா அ§பான~ 
ெபா¯ ேதைவ எ}பைத­, அவ§பான~ 
ெபா¯க¶ ேத§ ஒ}² எ}பைத­ “ 
அ§பான{ தாேல யவத பலிt 
     இனதான t }னலிxசி – ப§«தகu   
 ேகாமய பா «ைல~பா ேகாெநேத} 
ெவறிைல நƫ  
      ஆமிைதயா ரா|¢ ெசயலா” 
-ணபாட தா¢ சவீ வ~© 
எ}ற ெச­ளா உணரலா.  
ேத} அ§பான~ ெபா¯ளாவத}றி அவத~ 
 ெபா¯¶மாகி ேதக{ைத ந}னைலய 
ைவ{¢, வாத «தலிய ¬}² 
றuகைள­ ேபாt எ}பைத ேதர} 
²கிறாƫ. 
ேதைனபான ெச¢ வ|தா கப~பணக 
நu.   
Constituents  : Honey is mainly a mixture of dextrose ( grape sugar) 
and levulose ( fruit sugar). It also contains wax, Volatile 
oil, mucilage, coloring matter, formic acid , ash, ethereal 
oil, phosphates,  calcium, iron, fat soluble, water  soluble 
vitamins and a special protein.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
INGREDIENTS 
  
Zingiberoffcinale  Alpiniaofficinarum  
  
Piper nigrum  Anacyclus pyrethrum  
 
mhprp jpg;gpyp Piper longum  
 
  
 
 
 
  
 
 
 
 OBSERVATION AND RESULTS 
Results were observed with respected to the following criteria 
1.Age distribution 
2.Sex distribution 
3.Religion distribution 
4.Informant 
5.Diet 
6.Socio-economic status 
7.Paruvakaalangal 
8.Thinaigal 
9.Clinical features 
10.Uyirthathukkal 
11.Udalthathukkal 
12.Envagaithervugal 
13.Neikuri 
14.IP case sheet report 
15.OP report 
16.Investigation 
17.Results 
For this study results, 20 In Patients and 20 Out Patients were selected.  
 
 
 
 
 
 
 
 
 
 
 
1. AGE DISTRIBUTION: 
 
 
 
 
INFERENCE 
    Out of 40 cases 7.5% of cases belong to age group 1-3 years,   37.5  % of cases 
belong to age group of 4-6 years, 42.5   % of cases belong to age group of 7-10 
years and  12.5% of cases belong to age group 11-12 years. 
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S.No Age No of 
cases 
Percentage 
1. 0-1 Year 
Kappu and  Chenkeerai 
- - 
2. 1-3 Years 
Varugai,Thalattu, Sappani, Muttham 
3 7.50 
3. 4-6 Years 
Ambuli,Chitril,Chiruparai,Chiruther, 
Paethai(female) &Pillai(male) 
15 37.5 
4. 7-10 Years 
Paethumbhaiparuvam(female),Chiruparuvam(male) 17 42.5 
5. 11-12 Years 
Mangai(female), Valibam(male) 
5 12.5 
2.SEX DISTRIBUTION: 
S.No Sex No of cases Percentage 
1. Male 23 57.5% 
2. Female  17 42.5% 
 
 
 
 
 
 
Inference  
      Among 40 cases of study 23 were male (57.5%) and 17 were female (42.5%). 
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3.Religion distribution: 
 
S.No Religion No of cases Percentage 
1. Hindu  31 77.5 
2. Muslim  4 10 
3. Christian  5 12.5 
 
 
 
 
INFERENCE 
      Out 40 cases    77.5 % were Hindu, 10 % were Muslim and 12.5 % were 
Christian 
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4.INFORMANT: 
S.No Informant No of cases Percentage 
1. Mother 31 77.50 
2. Father 6 15 
3. Grand parents 3 7.5 
4. Others - - 
 
 
 
 
Inference 
According to this 77.5  % of cases were good reliability, 15  % of cases were fair 
reliability and 7.5% cases were  not reliable. 
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 5.DIET: 
S.No Food Habit No of cases Percentage 
1. Vegetarian  10 25 
2. Mixed  30 75 
 
 
 
 
 
INFERENCE 
      Out of 40 cases 25% were Vegetarian and remaining 75% mixed diet. 
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 6.SOCIO ECONOMIC STATUS 
S.No Socio Economic Status No of cases Percentage 
1. Poor  34 85 
2. Middle class 6 15 
3. Rich  - - 
 
 
 
 
 
Inference 
      Out of 40 cases 85 % belong to poor socio economic class and   15% belong to 
middle class. 
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7. DISTRIBUTION OF PARUVAKAALANGAL: 
 
S.No Paruvakaalangal No of cases Percentage 
1. Kaar(Aavani,Purattasi) (August 
to October) - - 
2. Koothir (Ayppasi,Karthigai) 
(October to December) - - 
3. Munpani (Markazhi,Thai) 
(December to February) 
17 42.5 
4. Pinpani (Maasi,Pankuni) 
(February to April) 
11 27.5 
5. Elavenil (Chitthirai,Vaikasi) 
(April to June) 12 30 
6. Muthuvenil (Aani,Aadi) 
(June to August) 
- - 
 
 
 
INFERENCE 
      Out of 40 cases   42.5 % of cases came during Munpanikaalam, 30% of cases 
of the incidence come under the Elavenilkaalam, 27.5 % of cases of the incidence 
come under the Pinpanikaalam. 
       The Table showed more  prevalence of  the disease under Munpanikaalam. 
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8. DISTRIBUTION OFTHINAIGAL (LANDS) 
 
S.No Thinai No of cases Percentage 
1. Kurinji (Hill) - - 
2. Mullai (Forest) - - 
3. Marutham(Fertile) 38 95 
4. Neithal (Coastal) 2 5 
5. Paalai (Desert) - - 
 
 
 
Inference 
 According to Siddha concept, no disease occurs to the people living in 
marutham, but people nowadays entirely differs from their ancestors both in 
dietary and other habits. And also the study was conducted in and 
aroundTirunelveli, amarutham land. So, Majority of cases are from this land. 
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 9. CLINICAL FEATURES 
S.No Signs and Symptoms  No of cases Percentage 
1. Wheeze 35 87.5 
2. Nocturnal cough 35 87.5 
3. Fever 15 37.5 
4. Headache 15 37.5 
5. Sinusitis 20 50 
6. Allergic rhinitis 16 40 
7. Running nose 16 40 
8. Loss of appetite 15 37.5 
9. Weight of loss 2 5 
10. Loss of appetite  15 37.5 
11. Constipation  8 20 
12. Cough without Expectorating 15 37.5 
 
 
 
INFERENCE  
 Major clinical symptoms reported to be Wheeze and Nocturnal cough. Most 
of the clinical signs were relieved after treatmet. 
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10.Uyirthathukkal 
a. DERANGEMENT OF  VATHAM 
 
S.No Type of vatham  No of cases Percentage 
1. Pranan ( ) 40 100 
2. Abanan  - - 
3. Viyanan  40 100 
4. Uthanan  40 100 
5. Samanan  40 100 
6. Nagan  - - 
7. Koorman  - - 
8. Kirukaran  30 75 
9. Devathathan  15 37.5 
10. Dhananjeyan
 
- - 
 
 
INFERENCE  
 According to this Pranan, Viyanan, Uthanan, Samanan has 100 %,  
Kirukaran has 75% and  Devathathan have lowest percentage of 37.5%.  
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B. DERANGEMENT OF PITHAM  
 
S.No Type of pitham No of cases Percentage 
1. Analagam ( ) 24 60 
2. Ranjagam  15 37.5 
3. Saathagam  40 100 
4. Pirasagam  8 20 
5. Aalosagam  - - 
 
 
 
INFERENCE  
 According to this, Saathagam has 100%, Analagam has 60 %, Ranjagam 
has 37.5 % and Pirasagam has 20%. 
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c. DERANGEMENT OF KABAM 
 
S.No Type of kabam No of cases Percentage 
1. Avalambagam  40 100 
2. Kilethakam  30 75 
3. Pothakam  - - 
4. Tharpakam  - - 
5. Santhikam  - - 
 
 
 
 
INFERENCE  
 According to this,Avalambagam has 100% and Kilethakam has 75%. 
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11. UDALKATTUGAL 
 
S.No UdalKattugal No of cases Percentage 
1. Saaram  40 100 
2. Senneer  15 37.5 
3. Oon  20 50 
4. Kozhuppu  20 50 
5. Enbu  - - 
6. Moolai  - - 
7. Sukkilam / 
Suronitham /
 
- - 
 
 
 
INFERENCE  
 According to this Saaram has 100%, Oon and  Kozhuppu have 50 % and 
Senneer has 37.5%. 
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12. EnvagaiThervugal 
 
S.No Udalthathukkal No of cases Percentage 
1. Naadi  
a. Vathakabanaadi 20 50 
b. Pithakabanaadi 15 37.5 
c. Kabapithanaadi 5 12.5 
2. Sparisam  30 75 
3. Naa  16 40 
4. Niram  10 25 
5. Mozhi  04 10 
6. Vizhi  - - 
7. Malam  10 25 
8. Moothiram  22 55 
 
 
 
Inference  
 According to this sparisam has highest percentage as 75%, Moothiram have 
55 % and mozhi have 10 % as lowest value. 
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 13. Neikuri 
S.No Character of urine  Neikuri 
reference 
No of cases Percentage 
1. Spreads like serpent Vathaneer 10 25 
2. Spreads like ring Pithaneer 4 10 
3. Spreads like pearl Kabaneer 26 65 
 
 
 
 
 
Inference  
 According to this Kabaneer have 65 %, Pithaneer have 10 %  and Vathaneer 
have 25 %. 
 
 
 
 
0
10
20
30
40
50
60
70
25
10
65
Neikuri 
1 Vathaneer
2 Pithaneer
3 Kabaneer
 14.Case reports of twenty cases for the diseases – Sooli kanam 
Post graduate department of Kuzhanthai Maruthuvam 
S. 
No. 
IP 
No. 
Name of 
The patient 
Age/ 
Sex 
Date of 
Admission Signs and Symptoms 
Date of 
Discharge Duration 
Total no of 
days 
treated 
Result 
1 618 Hari 5/MC 07.03.16 
Cough with 
expectoration, 
Wheeze,, Poor appetite 
     28.03.16 3 months 22    26 Good 
2 843 Rashima 7/FC 09.03.16 
Fever ,Running nose,  
Cough with 
expectoration, Loss of 
appetite 
28.03.16 1 month 20    28 Good 
3 835 Kalaiarasi 10/FC 28.03.16 
Cough with 
expectoration, Wheeze,  
Sinusitis 
27.04.16 15 days 29    19 Good 
4 832 Shivani 8/FC 28.03.16 
 Cough with 
expectoration, Wheeze,  
Constipation 
22.04.16 1 year 35    13 Good 
5 901 Suddalay 9/MC 02.04.16 Fever,Nocturnal Cough,Wheeze 30.04.16 16 days 28    20 Good 
6 905 Roshi 12/FC 02.04.16 
Fever ,Running nose,  
Cough with 
expectoration, Loss of 
appetite. 
19.04.16 2 weeks 17    31 Good 
7 912 Ashwin 4/MC 03.04.16 Cough with expectoration, Wheeze   30.04.16 2 months 28    20 Good 
 8 1060 Abdul Rahman 11/MC 20.04.16 
Fever ,Running nose,  
Cough with 
expectoration, Loss of 
appetite, Sinusitis 
13.05.16 45 days 23    25 Good 
9 1205 Isravel 10/MC 05.05.16 
Cough with 
expectoration, 
Sneezing, Wheeze   
31.05.16 1 week 26    22 Good 
10 1257 Rajini 8/FC 12.05.16 
Fever, Sneezing, 
Headache, Running 
nose, Cough with 
expectoration 
26.05.16 8 days 14    34 Good 
11 1267 Aisha 11/FC 13.05.16 
Cough with 
expectoration, Wheeze, 
Constipation,Running 
nose 
 
 
     25.05.16 
 
 
6 days 
 
 
12    36 
 
 
Moderate 
12 1269 Murugan 7.5/MC 13.05.16 
Fever, Cough 
withexpectoration, 
Wheeze 
01.06.16 28 days 18    30 Good 
13 1270 Thomas 9/MC 13.05.16  Cough with expectoration, Wheeze 01.06.16 17 days 18    30 Good 
14 1357 Sriprammatchi 5/FC 23.05.16 
Fever, Cough with 
expectoration, 
Headache, Running 
nose,loss of appetite 
06.06.16 6 days 14    34 Good 
 15 1430 GomathiSankar 3.5/FC 31.05.16 
  Cough 
withexpectoration, 
Wheeze, Allergic 
Rhinitis 
20.06.16 20 days 22    26 Good 
16 1431 Subathra 3.5/FC 31.05.16 
Cough with 
expectoration, 
Headache, Sneezing, 
Wheeze 
18.06.16 25 days 20    28 Good 
17 1455 Charupriya 2.5/FC 02.06.16 
Cough with 
expectoration, 
Headache, Wheeze 
10.06.16 3 weeks 9    39 Poor 
18 1456 Rasi 10/MC 02.06.16 
Cough 
withexpectoration, 
Wheeze, Sinusitis 
10.06.16 25 days 9    19 Good 
19 1457 Dinesh 6/MC 02.06.16 
Fever, Cough with 
expectoration, 
Headache, 
loss of appetite 
06.06.16 16 days 5    24 Good 
20 1458 Uma 10/FC 02.06.16 
Fever, Cough with 
expectoration, Wheeze, 
Sinusitis 
16.06.16    2 weeks 15    14 Moderate 
 
 
  
 
15.OUTPATIENTS RECORDS 
 
S.No. OP No. Name Age/ sex 
No. of days 
treated 
Remarks 
1 8080 Sriram 6/MC 45 Good 
2 8207 Renuka 3/FC 45 Good 
3 9341 Kaleeshwari 7/FC 36 Good 
4 9474 Anand 12/MC 25 Good 
5 9909 Abisha 7/MC 36 Good 
6 10346 Jo 5/MC 30 Good 
7 10362 Ganesh Babu 5/MC 16 Moderate  
8 10413 Stalin 5/MC 21 Good 
9 10966 Maragadham 11/FC 45 Good 
10 11039 Anushka 9/FC 28 Good 
11 13416 Nagarajan 11/MC 45 Good 
12 15216 Joshua 5/MC 30 Good 
13 15330 Zeenath 7/FC 35 Good 
14 15370 Papu 5/FC 18 Moderate 
15 15386 Anandhan 10/MC 30 Good 
16 18121 Kasthoori 7/MC 25 Good 
17 18419 Ajith 4/MC 15 Poor 
18 20443 Mukilan 5/MC 18 Moderate 
19 22320 Harivishwa 3/MC 28 Good 
20 23429 Karthik 4/MC 30 Good 
 
 
 
 
 
 16- Lab Investigation 
S.
N
o.
 
IP
 N
o.
 
Name of 
The patient 
Age/ 
Sex 
X – ray chest SPUTUM 
WBC total 
count 
Cu.mm 
Hematological investigation 
AEC 
ESR 
Hbgm % WBC differential count / cu.mm Mm /hr 
BT AT BT AT BT AT BT AT BT AT BT AT P% L% E% P% L% E% 
1   618 Hari 5/MC Nor Nor -Ve 9100 8700 55 40 5 54 45 1 670 320 19 09 8.1 10 
2   843 Rashima 7/FC Bro Nor -Ve 8300 7960 60 34 6 56 42 2 360 280 15 10 11 12 
3   835 Kalaiarasi 10/FC Bro Nor -Ve 8500 7900 55 40 5 53 45 2 1460 670 22 10 9.3 10.8 
4   832 Shivani 8/FC Nor Nor -Ve 9500 9100 60 35 5 55 43 2 Nil Nil 13 07 11 12 
5 901 Suddalay 9/MC Nor Nor -Ve 9100 8950 50 46 4 58 40    2        Nil Nil 13 10 12 13 
6 905 Roshi 12/FC Nor Nor -Ve 8200 7500 52 40 8 58 40 2 1260 560 10 08 11 12.5 
7 912 Ashwin 4/MC Nor Nor -Ve 9800 9300 80 17 3 67 32 1 Nil Nil 15 10 9.1 11 
8 1060 Abdul Rahman 11/MC Bro Nor -Ve 8600 8200 65 31 4 55 43 2 Nil Nil 16 09 12.2 13.5 
9 1205 Isravel 10/MC Bro Nor -Ve 9050 8930 56 40 4 55 44 1 Nil Nil 08 05 9.8 10.5 
10 1257 Rajini 8/FC Nor Nor -Ve 9000 9000 56 42 2 52 47 1 Nil Nil 10 06 12.3 13.8 
11 1267 Aisha 11/FC Nor Nor -Ve 9100 8900 49 46 5 60 36 4 360 330 10 05 10.8 11.2 
12 1269 Murugan 7.5/MC Nor Nor -Ve 7500 7000 54 42 4 58 40 2 250 230 38 20 10 11 
13 1270 Thomas 9/MC Bro Nor -Ve 8100 8000 64 33 3 66 33 1 340 320 20 14 11 12.1 
14 1357 Sriprammatchi 5/FC Nor Nor -Ve 8600 8400 52 44 4 57 42 1 Nil Nil 20 08 9 10 
15 1430 GomathiSankar     3.5/FC Nor Nor -Ve 11500 9700 53 42 5 53 45 2 Nil Nil 15 10 10 11.5 
16 1431 Subathra 3.5/FC Nor Nor -Ve 8000 8000 58 40 2 60 39 1 Nil Nil 06 06 10 12 
17  1455 Charupriya 2.5/FC Nor Nor -Ve 12800 9450 65 27 8 62 30 8 1300 1280 38 35 9 9 
18  1456 Rasi 10/MC Bro Nor -Ve 8000 7500 50 44 6 56 42 2 370 320 18 10 10.6 11.2 
19  1457 Dinesh 6/MC Nor Nor -Ve 9100 9000 53 40 7 52 46 2 290 250 12 08 11 12 
20 1458 Uma 10/FC Nor Nor -Ve 8600 8300 65 31 4 60 38 2 320 300 16 10 13.8 14 
BT – Before Treatment ; AT – After Treatment ; P – Polymorphs ; E – Eosinophils ; ESR – Erthrocyte Sedimentation ; HB – Haemoglobin ; WBC – White blood cell ; 
AEC- Absolute Eosinophil Count;Bro – Bronchitis 
 S.
N
o.
 
IP
 N
o.
 Name of 
The patient 
Age/ 
Sex 
Urine Analysis Motion analysis 
BT AT BT AT 
Alb Sug Dep Alb Sug Dep 
Ova 
Cyst 
Occu
lt 
Bloo
d 
Ova 
Cyst 
Occult 
Blood 
1 618 Hari 5/MC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
2 843 Rashima 7/FC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
3 835 Kalaiarasi 10/FC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
4 832 Shivani 8/FC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
5 901 Suddalay 9/MC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
6 905 Roshi 12/FC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
7 912 Ashwin 4/MC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
8 1060 Abdul Rahman 11/MC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
9 1205 Isravel 10/MC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
10 1257 Rajini 8/FC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
11 1267 Aisha 11/FC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
12 1269 Murugan      7.5/MC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
13 1270 Thomas 9/MC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
14 1357 Sripremmatchi 5/FC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
15 1430 GomathiSankar 3.5/FC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
16 1431 Subathra 3.5/FC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
17 1455 Charupriya 2.5/FC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
18 1456 Rasi 10/MC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
19 1457 Dinesh 6/MC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
20 1458 Uma 10/FC Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil 
 
Alb – Albumin Sug – Sugar ; Dep – Deposit ; NAD – No abnormal Deposits ; Nor – Normal ;L /min – Liter / 
minute 
 
17. RESULT 
Among 40 cases, the results were observed as follows 
S.No Results  No of cases Percentage 
1. Good 32 80 
2. Moderate 5 12.5 
3. Poor 3 7.5 
 
 
 
INFERENCE: 
 80 % of the cases showed Good results and 12.5% of the cases showed 
Moderate results and 7.5 % of the cases showed Poor response. These results are 
based on the clinical improvement. 
 
 
 
 
 
 
 
 
 
1 2
S.No Results 0
1 Good 80
2 Moderate 12.5
3 Poor 7.5
80
12.5 7.5
0
10
20
30
40
50
60
70
80
90
Result
 DISCUSSION 
SooliKanam is a paediatric problem, the clinical features of which are 
clearly described in various Siddhar texts. This disease most probably correlates 
with Childhood Asthma, which limits the daily activities of child and interferes 
with sleep and school absenteeism. 
In this study, 20 cases were treated at the Out-Patientpost graduate 
department and 20 cases were treated at the In-Patient ward. Siddha methods 
ofdiagnosis were carried out and recorded in the selection proforma and the 
diagnosis was confirmed with the help of modern investigations. The patients were 
treated with the drug “BALAKABAHARI MATHIRAI” and results were 
observed. The observations are discussed here under.   
 
Distribution according to age 
 This study indicates that children under the age group of 7-10 years (42.5 
%) are mostly affected. Since they contribute to school going age they may be 
exposed to a variety of allergens. 
Distribution according to sex 
 Among 40 cases of study 57.5 % were male children and 42.5 % were 
female children.  
Distribution according to religion 
 Out of 40 cases 77.5 % were Hindu, 12.5 % were Christian and 10 % were 
Muslim. 
Informant 
 According to this 77.50 % of cases were good reliability, 15 % of cases 
were fair reliability and 10 % of cases were not reliable.  
 
 
Diet history 
 According to diet history 75 % of cases had mixed diet and 25 % of cases 
had vegetarian diet. The highest incidence of cases was observed in mixed diet of 
food habits. 
 Distribution according to socio economic status 
 Most of the patients, around 85 % were belonged to poor economic status, 
15% were belonged to middle class. Due to poverty, malnutrition, overcrowding 
and  
unhygienic practices this disease is more prevalent among the poor.  
Distribution of land 
 Among the selected 40 cases 95 % of them were from Marutham land and 
5% of them were from Neithal land. This is due to the fact that the study was 
conducted at Tirunelveli, a Marutham land and so majority of the cases were from 
this land. 
Distribution of paruvakaalangal 
Among the selected 40 cases, according to paruvakaalam the highest 
distribution of 42.5 % was noticed in munpanikaalam, 30 % was noticed in 
ElavenilKaalam and 27.5 % was noticed in PinpaniKaalam. 
Distribution according to Aetiological factors 
 Inhaled Allergens, cool foods and beverages contributes 60 to 80 % of the 
most common Etiological factors. Family history of allergy was found in 50 % of 
the cases. 80% of cases were affected by the Climatic changes. 70% of cases were 
with Etiology of Respiratory infection. 
Distribution of Clinical features  
 Almost all the cases were presented with Wheeze and Nocturnal cough.    
37.5 % of cases had fever and vomiting. 40% of cases were presented with 
Sinusitis and Allergic Rhinitis. 
Distribution of illness 
Distribution according to uyirthathukkal 
a. Derangement of Vatham 
 Due to derangement of vatham,Pranan,Viyanan,Uthanan, Samanan were 
affected in all the 100 % of the patients. Kirukaran was affected in 75 % of the 
patients andDevathathan was affected in 37.5 % of the patients. 
 
 
 b. Derangement of Pitham 
 Due to derangement of pitham, Saathgam was affected in all the 100 % of 
the patients. Analagam was affected in 60 % of the patients. Ranjagam was 
affected in     37.5 % of the patients.  Pirasagam was affected in 20 % of the 
patients.   
c. Derangement of  Kabam 
 Due to derangement of Kabam, Avalambagam was affected in all the 100 % 
of the patients. Kilethakam was affected in 75 % of the patients. 
 
Distribution according to UdalKattugal 
 According to UdalKattugal ,Saaram was affected in all the 100 % of the 
patients. Oon and Kozhuppu were affected in 50%of the patients. Senneer was 
affected in  37.5 % of the patients.  
Distribution according to Envagaithervugal 
 According to Envagaithervugal, Sparisam was affected in 75 % of the 
patients. Moothiram was affected in 55 % of the patients. Naa was affected in 40 
% of the patients. Niram and Malam were affected in 25 % of the patients. 
Distribution according to Neikuri 
 According toNeikuri most of the patients affected by Kabaneer as 65 % of 
patients, Vathaneer as 25 % and Pithaneer as 10%. Routine 
Lab investigation 
 Routine examinatios of Blood, Urine and Motion were done during 
admission and discharged. In most of the cases ESR and Total Leucocyte count 
was elevated before treatment. Mantoux test was done for differential diagnosis to 
exclude Primary Complex. 
Radiological Findings 
 Theradiological finding of majority of cases shows the evidence of 
Pulmonary Hyperventilation associated with the evidence of Obstructive 
Pulmonary Disease and Bronchitis. 
 
 
 Biochemical Analysis 
 Qualitative analysis of the trial drug revealed the presence of Ferrous Iron 
which is more soluble and readily absorbable form that helps in treating children 
who are associated with Anaemia. The study also indicates the presence of 
Calcium, Sulphate, Chloride, Starch, Tannic acid, Amino acid and Unsaturated 
compounds. 
Antimicrobial Activity 
 Antimicrobial activity of BalakabahariMathiraishowd that it inhibited the 
growth of bacterial strains of  Escherichia coli, Streptococcus pneumonia and 
Staphylococcus aureus. 
Pharmacological Analysis 
 Pharmacological Analysis showed the drug has significant Antihistamine 
and Antispasmodic actions. 
Selection of the Trial Drug 
 The selection of the trial drug is based on the Pharmacological action of the 
drug, both in Siddha and Modern aspects. 
Treatment 
 The trial medicine choosen for treatment for SooliKanam was 
BalakabahariMathirai. The ingredients of this drug are found to have suitable 
properties for treating SooliKanam. All the patients were strictly advised to follow 
pathiyam. They were also advised to follow personal hygiene and other preventive 
measures. 
 The trial medicine selected for this study is very effective because the 
actions mentioned in each drug, which are used in this medicine contains 
Expectorant, Antispasmodic, Carminative, Stimulant, Tonic, Alterative, Digestive, 
Anodyne, Emollient, Hepatic tonic, Emetic and Demulcent actions which are 
beneficial for this disease. The pothugunam of every drug told by Siddhars is also 
beneficial. 
 The following suvaigal are present on the ingredients of 
BalakabahariMathirai 
    Bitter – It equalises the vitiated Pitham and vitiated kabam. 
     Spicy – It equalises the vitiated kabam. 
    Astringent – It equalises the vitiated Pitham and vitiated kabam. 
    Sweet – It equalises the vitiated Pitham and vitiated vadham. 
 
 BalakabahariMathirai reduces cough, wheeze, nasal discharge, loss of 
appetite and increases digestive and absorption functions. 
Result  
 Satisfactory improvement was reported in 3 days of commencement of 
treatment. Out of 40 cases 32 patients (80%) showed Good response with 
remarkable relief of symptoms. Moderate result was observed in 5 patients 
(12.5%) with reduction in signs ad symptoms. The result was poor in 3 patients 
(7.5%), as there was no significant improvement of symptoms. 
  
 SUMMARY 
 The aim of this dissertation subject is to assess the efficacy of trial drug 
“BalakabahariMathirai” for “SooliKanam” without any adverse effects.   
 The SooliKanam has been correlated with that of Childhood Asthma with 
evidence of literature. 
 Clinical diagnosis and selection of cases was based on clinical features described 
in Balavagadam text book and also using questionnaire. 
 The medicine chosen for treatment and management of SooliKanam was 
BalakabahariMathirai, ½ to 1 tablet (according to age) internally twice a day. 
 The trial drug selection is based on its siddha pharmacological action to pacify the 
deranged vatham, pitham and kabam and also due to its Immuno modulatory and 
Anti - asthmatic effect of ingredients.  
 Forty children were diagnosed with Soolikanam clinically and they were observed 
for clinical diagnosis, laboratory diagnosis, Peak Expiratory Flow rate during the 
treatment and the results were dealt in the proforma. 
 Laboratory diagnosis was done by modern methods of examinations. 
 The documentation of observations made during the clinical study showed that 
the drug is clinically effective. 
 The biochemical analysis of the trial medicine had Calcium, Sulphate, Chloride,  
Ferrous iron, Tannic acid, Unsaturated compound and Amino acid  which adds to 
the clinical prognosis of SooliKanam by BalakabahariMathirai. 
 Antibacterial activity of BalakabahariMathiraishowed that it inhabited the 
growth of bacterial strain against Streptococcus pneumonia, Staphylococcus 
aureus and Escherichia coli. 
 In the pharmacological analysis, the trial drug BalakabahariMathirai had 
significant Anti-Histamine action an Anti-spasmodic action which by the virtue of 
controlling the airway hyper responsiveness help to improve the patients quality 
of life. 
 With these benefits BalakabahariMathiraican be deemed as an effective 
Medicine for Soolikanam [Childhood Asthma].  
 CONCLUSION 
 
 The treatment of BalakabahariMathirai for SooliKanam showed good 
response. 
 No adverse effect were noticed during the course of treatment  
 The ingredients of trial medicine are easily available and harmless to 
children  
 The cost of the trial medicine is comparatively very low. 
 
Therefore it is concluded that the trial drug ‘‘BalakabahariMathirai’’ along 
with the modalities of Pranayama and Yogasanas will benefit the society in 
treating Childhood Asthma. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
 
  
GOVERNMENT SIDDHA MEDICAL COLLEGE  
PALAYAMKOTTAI 
Certificate of Gunapadam Authenticity 
 Certified the following mineral drug used in Siddha formulation 
BALAKABAHARI MATHIRAI for the management of SOOLI KANAM 
(BRONCHIAL ASTHMA) taken up for Post Graduation Dissertation Studies by Dr. 
K.BALAJI (Reg. No. 321314001) PG Dept, of Kuzhanthai Maruthuvam are correctly 
identified and authenticated through Visual Inspection / Organoleptic Characters / 
Experience, Education and Training Morphology Microscopical methods. 
 
Sl.No. Name Chemical Name 
1. Indhuppu Sodium Chloride Impura 
 
 
 
 
 
 
 
 
 BIO-CHEMICAL ANALYSIS OF BALAKABAHARI MATHIRAI 
Preparation of the extract:  
 5gms of the drug was weighed accurately and placed in a 250ml clean beaker then 
50ml of distilled water is added and dissolved well. Then it is boiled well for about 10 
minutes. It is cooled and filtered in a 100ml volumetric flask and then it is make up to 
100ml with distilled water.  This fluid is taken for analysis. 
QUALITATIVE ANALYSIS 
S.NO. EXPERIMENT OBSERVATION INFERENCE 
1.  TEST FOR CALCIUM 
2ml of the above prepared 
extract is taken in a clean test 
tube. To this add 2ml of 4% 
Ammonium oxalate solution 
A white precipitate  
is formed 
Indicates the 
presence of 
calcium  
2. TEST FOR SULPHATE 
2ml of the extract is added to 
5% Barium chloride solution. 
A white precipitate  
is formed 
Indicates the 
presence of 
sulphate 
3.  TEST FOR CHLORIDE 
The extract is treated with 
silver nitrate solution 
A white precipitate  
is formed 
Indicates the 
presence of 
chloride 
4. TEST FOR CARBONATE 
The substance is treated with 
concentrated Hcl. 
No brisk 
effervescences is 
formed   
Absence of 
carbonate 
5. TEST FOR STARCH 
The extract is added with 
weak iodine solution 
Blue colour is  
formed 
Indicates the 
presence of starch 
6.  TEST FOR FERRIC IRON 
The extract is acidified with 
Glacial acetic acid and 
potassium ferro cyanide. 
No blue colour is 
formed 
Absence of ferric  
iron indicates the 
absence 
7. TEST FOR FERROUS 
IRON  
The extract is treated with 
concentrated Nitric acid and 
Blood red colour is 
formed 
Indicates the 
presence of 
Ferrous iron 
 Ammonium thiocyanate 
solution 
8.  TEST FOR PHOSPHATE 
The extract is treated with 
Ammonium Molybdate and 
concentrated nitric acid 
No yellow  
precipitate is 
formed 
Absence of 
phosphate 
9.  TEST FOR ALBUMIN 
The extract is treated with 
Esbach’s reagent 
No yellow  
precipitate is 
formed 
Absence of albumin  
10.  TEST FOR TANNIC ACID 
The extract is treated with 
ferric chloride. 
Blue black 
precipitate is 
formed 
Indicate the 
presence of Tannic 
acid 
11.  TEST FOR 
UNSATURATION 
Potassium permanganate 
solution is added to the extract 
It gets decolourised  Indicates the 
presence of 
Unsaturated  
compound 
12.  TEST FOR THE 
REDUCING SUGAR 
5ml of Benedict’s qualitative 
solution is taken in a test tube 
and allowed to boil for 2 
minutes and add 8-10 drops of 
the extract and again boil it for 
2 minutes. 
No colour change 
occurs 
Absence of 
reducing sugar 
13.  TEST FOR AMINO ACID 
One or two drops of the 
extract is placed on a filter 
paper and dried well. After 
drying, 1% Ninhydrin is 
sprayed over the same and 
dried it well. 
Violet colour is 
formed  
Indicates the 
presence of Amino 
acid 
14. TEST FOR ZINC 
The extract is treated with 
Potassium Ferrocyanide. 
No white 
precipitate is 
formed 
Absence of zinc 
Inference: 
 The above analysis indicates the presence of Ferrous Iron, Calcium, Sulphate, 
Chloride, Starch, Amino acid, Tannic acid and Unsaturated compound. 
 PHARMACOLOGICAL ANALYSIS  
ANTISPASMODIC ACTIVITY OF SIDDHA PREPARATION 
BALAKABAHARI MATHIRAI IN SWISS ALBINO MICE 
Introduction 
 The present study was carried outto  see the effect of siddha preparation 
BalakabahariMathiraion muscle relaxant activity. 
Material and methods 
Animals used 
 Swiss albino mice of either sex with weighing 18-26 g were used. The 
animals were maintained on the suitable nutritional and environmental condition 
throughout the experiment. The animals were housed in polypropylene cages with 
paddy house bedding under standard laboratory condition for an acclimatization 
periods of 7 days prior to performing the experiment. The animals were fed with 
commercially available rat pelleted diet. Water was allowed ad libitum under strict 
hygienic conditions. 
Rotarod 
 The rotarod apparatus consists of a metal rod (3 cm diameter) coated with 
rubber attached to a motor with the speed adjusted to 2 rotations per minute. The 
rod is 75 cm in length and is divided into 6 sections by metallic discs, allowing the 
simultaneous testing of 6 mice. The rod is in a height of about 50 cm above the 
tabletop in order to discourage the animals from jumping off the roller. Cages 
below the section serve to restrict the movements of the animals when they fall 
from the roller. Swiss albino mice underwent a pretest on the apparatus. Only 
those animals, which had demonstrated their ability to remain on the revolving rod 
(20 rpm) for 5 min, were used for the test.(1,2,3). Swiss albino mice were divided 
into four groups consisting of six animals each. Group I served as control which 
received saline solution , animals of group II received standard drug Diazepam at a 
dose of (5mg/kg, i.p.) while Group III & IV received the siddha preparation 
BalakabahariMathirai at a dose of 15mg/kg and 30 mg/kg, p.o. The animals were 
placed on the rotating rod and fall off time i.e, when the animal falls from the 
rotating rod, was recorded, which was taken as grip strength. 
  
Traction test(4) 
 Placing the forepaws of the mice in a small twisted wire rigidly supported 
above the bench top did the screening of animal. Normally the mice grasp the wire 
with the forepaws, and place at least one hind foot on the wire without 5 second 
when allowed to hang free.The test was conducted on four groups of animals (n=8) 
that were previously screened, 30 min after the administration of siddha 
preparation BalakabahariMathirai, diazepam (5 mg/kg) and saline solution as a 
vehicle control. Inability to put up at least one hind foot on the wire is counted as 
negative value. 
Statistical analysis 
 The data obtained in present investigation was subjected to statistical 
analysis. All results are expressed as Mean ± SEM (standard error of mean); Six 
animals in each group. All statistical  comparisons were made by Newmannkeuls 
multiple range tests after conducting one -way ANOVA. 
Results and Conclusion 
Rotorod test 
 In this test, siddha preparation BalakabahariMathirai(15 and 30 mg/kg) 
both significantly reduced the time spent by the animals on revolving rod when 
compared to Control (P<0.05). The standard drug (diazepam) also showed 
significant effect when compared to control (P<0.01). (Table I). 
Traction test 
 In traction test, siddha preparation BalakabahariMathirai (15 and 30 
mg/kg) both significantly decreases the muscle co-ordination activity of mice 
compared with Control (p< 0.05).(Table II). 
The siddha preparation BalakabahariMathirai (15 and 30 mg/kg)was 
pharmacologically screened for its muscle relaxant study. The result indicates that 
siddha preparation BalakabahariMathirai(15 and 30 mg/kg) possess a significant 
skeletal muscle relaxant activity in experimental animals. At dose of 15 and 30 
mg/kg it showed highly significant skeletal muscle relaxant activity at 30min of 
duration.  Further studies are in progress to isolate the active constituents 
 responsible for this activity. The muscle relaxation may be produced due to 
depolarizing blockage of neuromuscular junction.Based on the results of the 
present study, we conclude that the siddha preparation BalakabahariMathirai (15 
and 30 mg/kg) possess significant skeletal muscle relaxant activity. However, 
further studies are necessary to find the exact mechanism of skeletal muscle 
relaxant effect and to isolate the active compound(s) responsible for this 
pharmacological activity. 
 
Table I: Effect different treatment on duration of time spent on rotarod 
Group  Dose 0 minutes 30 minutes 
Normal control 10mg/kg saline 330.25 ± 22.85  322.7±24.85 
Diazepam 5mg/kg i.p 335.8±24.90 105.4±10.50** 
BalakabahariMathirai 15mg/kg p.o 320.5±22.80 185.5±14.20* 
BalakabahariMathirai 30mg/kg p.o 324.6±23.55 210.2±15.80* 
Values are expressed in mean± SEM; n=6; *p<0.05, *p<0.01 considered highly 
significant 
 
Table II: Effect of different treatment on motor co-ordination in mice 
Group  Dose  % Response 
Normal control 10mg/kg saline 0 
Diazepam 5mg/kg i.p 100 
BalakabahariMathirai 15mg/kg p.o 69* 
BalakabahariMathirai 30mg/kg p.o 61* 
 
Values are the percentage animals showing negative results; 
n = 6; *p< 0.05 compared with control (Chi-square test). 
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 ANTIHISTAMINIC AND ANTIANAPHYLACTIC ACTIVITY OF SIDDHA 
FORMULATION OF BALAKABAHARI MATHIRAI 
 
Introduction 
Allergy is one of the common diseases that affect mankind with diverse 
manifestations. The prevalence of allergy and asthma has risen in the recent years despite 
an improvement in the general health of the population.[1] Allergic diseases are 
responsible for significant morbidity and have severe economic impact.[2] Various 
epidemiological studies have identified the causes for an increase in the prevalence of 
upper and lower respiratory tract allergic diseases. Some of the postulated reasons are 
increasing environmental pollution [3] and increased predisposition of individuals 
producing excessive IgE through a major change in the gene pool, changing lifestyles, and 
an increasing awareness of the disorders.[4] Intensive research during the last several 
decades has highlighted the role of lymphocytes, immunoglobulins, mast cells, and 
various autacoids in the etiopathogenesis of allergic conditions. Inspite of the voluminous 
literature on the subject, the treatment of allergic diseases continues to be far from 
satisfactory. The available treatment options for upper and lower respiratory tract allergic 
diseases have major limitations owing to low efficacy, associated adverse events, and 
compliance issues.[5]  
 
AYUSH, an Indian system of medicine, has described several drugs from 
indigenous plant sources for use in the treatment of bronchial asthma and allergic 
disorders. In the present study, the effects of Siddha formulation of balakabahari mathirai 
were studied on the active anaphylaxis and mast cell stabilization in rats, and histamine-
induced bronchospasm in guinea pigs.  
Materials and Methods 
Animals 
 
Inbred Wistar rats (175–200 g) and guinea pigs (400–600g) of either sex housed 
in standard conditions (temperature22 ± 2° C, relative humidity 60 ± 5% and 12 h 
light/dark cycle) were used. They were fed with standard pellet diet and water ad libitum. 
The Institutional Animal Ethics Committee approved the experimental protocol. 
Histamine and horse serum were procured from Sigma Chemicals and toluidine blue from 
Loba-Chemie, Mumbai. Elisa kit for IgE was supplied by Orion diagnostics, Espoc, 
 Finland. All other chemicals and reagents were procured from Hi-Media Laboratories 
limited, Mumbai. 
 
Mast cell stabilizing activity 
 
Treatment protocol 
 
Twenty-four rats were divided into Five groups of six animals in each group.  
 
Group I       served as control and received vehicle (water). 
Group II     (sensitized control group) 
GroupIII     served as the treatment control, which was treated with balakabahari 
mathirai  
 at a dose of 200mg/kg body weight, in oral route. 
Group IV    served as the treatment control, which was treated with balakabahari 
mathirai       
                        at a dose of 400 mg/kg body weight, in oral route. 
 
In group11 to group 1V were sensitized by injecting 0.5 ml of horse serum 
subcutaneously along with 0.5 ml of triple antigen containing 20,000 million Bordetella 
pertussis organisms (Serum Institute of India Ltd.,Pune), Once a day for 14 days.  
 
On day 14, the rats were sacrificed 2 h after the treatment and the intestinal 
mesentry was taken out for the study on mast cells. Mesentries along with intestinal 
pieces were excised and kept in Ringer Locke solution (NaCl 154, KCl 5.6, CaCl2 2.2, 
NaHCO3 6.0, glucose 5.55 mM/L of distilled water) at 37oC. The mesenteric pieces were 
challenged with 5% horse serum for 10 min after which the mast cells were stained with 
1.0% toluidine blue and examined microscopically for the number of intact and 
degranulated mast cells.[6] 
 
 
 Histamine-induced bronchospasm in guinea pigs 
Bronchospasm was induced in guinea pigs by exposing them to 1% histamine 
aerosol under constant pressure (1 kg/cm2) in an aerosol chamber (24 × 14 × 24 cm) 
made of perplex 
Glass,of the three groups of six animals each. 
 
Group I served as control. 
GroupII     served as the treatment control, which was treated with balakabahari 
mathirai   
 at a dose of 200 mg/kg body weight, in oral route. 
Group III    served as the treatment control, which was treated with balakabahari 
mathirai       
                        at a dose of 400 mg/kg body weight, in oral route. 
         The animals were exposed to 1% histamine aerosol under constant pressure (1 
kg/cm2) in an aerosol chamber on day 0 without any treatment. The end 
point,preconvulsive dyspnea (PCD) was determined from the time of aerosol exposure to 
the onset of dyspnea leading to the appearance of convulsions.[7] As soon as PCD 
commenced, the animals were removed from the chamber and exposed to fresh air. This 
PCD was taken as day 0 value. On days 1 and 5, 
2 h after the administration of the drug, the time for the onset of PCD was recorded as on 
day 0. 
Statistical analysis 
The results of various studies were expressed as mean ± SEM and analyzed 
statistically using one-way ANOVA, followed by Newmann keul’s multiple range tests. 
P<0.05 was considered statistically significant.The analysis was performed using 
Graphpad Prism software package (Version 4.0). 
RESULTS 
Mast cell stabilizing potential of balakabahari mathirai  Antigen challenge resulted 
in significant degranulation of the mesentric mast cells. Pretreatment of sensitized 
animals with balakabahari mathirai at a dose of 200mg/kg and 400mg/kg, p.o., for 2 
weeks resulted in a significant reduction in the number of disrupted mast cells (P <0.001) 
when challenged with horse serum.  
 
 Effect on histamine-induced bronchospasm 
balakabahari mathirai  at a dose of 200mg/kg and 400mg/kg p.o., significantly 
prolonged the latent period of PCD (P <0.001) as compared to control, following 
exposure to histamine aerosols on day 5 [Table no. 2]. 
 
Discussion 
Experimental animal model of asthma is characterized by allergen-induced 
immediate airway constriction and late airway reactivity to a pharmacological 
vasoconstrictor such as histamine and leukotrienes. Histamine is a central mediator in the 
pathogenesis of allergic and inflammatory disorders. In the present study, balakabahari 
mathirai prolonged the latent period of PCD in guinea pigs following histamine aerosol. 
This may be suggestive of an antihistaminic activity following treatment with 
balakabahari mathirai. 
  Antigen challenge, in sensitized animals, results in the degranulation of mast cells, 
which is an important feature of anaphylaxis. In the present study, balakabahari mathirai  
showed marked protection against the mast cell degranulation following antigen 
challenge in sensitized animals. Mast cell stabilizing activity of balakabahari mathirai 
may be attributed to the presence of active constituents which are known for their mast 
cell stabilizing potential against antigen–antibody reaction and/or due to the suppression 
of IgE antibody production, which is responsible for degranulation mast cells.[8]  
This antianaphylactic and antihistaminic effect may be caused by the stabilization 
of the mast cell membrane, suppression of IgE, and inhibition of pathological effects 
induced by the release of inflammatory mediators in balakabahari mathirai treated 
animals. All the above findings lend credence to the beneficial use of balakabahari 
mathirai  in the treatment of asthma and related conditions. 
However, further studies with other experimental models, especially to explore the role of 
cytokines are warranted to substantiate the antiasthmatic and antiallergic activity of 
balakabahari mathirai. 
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 ANTIMICROBIAL STUDIES 
Aim  
To study the Antimicrobial action of “BalakabahariMathirai” by “paper disc 
agar diffusion method” (Kirby – bauyer method). 
Medium 
 Muller Hinton Agar 
Components of Medium  
Beef extract  - 300 g /lit 
Agar   - 17 g/lit 
Starch   - 1.5 mg/lit 
Casein Hydrolysate  - 17.5 g / lit 
Distilled water   - 1000 ml 
pH   - 7.6 
Procedure  
Preparation of inoculum 
 The given microorganism is inoculated in 1ml of peptone water under sterile 
condition. The inoculum is incubated at 37˚C for 2 hrs then the turbidity of the inoculums 
is adjusted to 0.5µc farland turbidity standard. The inoculum was poured in a Muller 
Hinton agar plate and uniformly spreaded over the plate.  The excess inoculum was 
discarded.  
 
Disc preparation  
 The known quantity of the given chemical compound is impregnated in a 6mm 
diameter filter paper disc and applied over the inoculum. Then the Muller Hinton agar 
plate is incubated at 37˚C for overnight. The zoneclearance is measured with a scale and 
the sensitivity of the organisms to the given trail drug is assessed.  
The diameter of zone of inhibition was observed and recorded.  
 
 
 
 
 
 
 
 TABULATION OF ANTIMICROBIAL ACTIVITY OF TRIAL MEDICINES 
S.No. 
 
Drug Organism Sensitivity 
Zone 
size of 
drug  
Zone size 
of control 
(Amikacin) 
1. BALAKABAHARI 
MATHIRAI 
Staphylococcus 
aureus 
Moderate 
Resistant 
8mm 15mm 
2. BALAKABAHARI 
MATHIRAI 
Streptococcus 
pneumoniae 
Sensitive 10mm 16mm 
3. BALAKABAHARI 
MATHIRAI 
Escherichia coli Sensitive 12mm 15mm 
 
  
  
Streptococcus pneumonia 
 
 
 Staphylococcus aureus 
 
 
Escherichiacoli 
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 GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI 
PG DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
CONSENT FORM 
 
An open clinical study to evaluate the safety and efficacy of Siddha sasthric 
formulation “ BalakabahariMathirai” for the management of SooliKanam 
(Childhood Asthma) 
CERTIFICATE BY INVESTIGATOR  
I certify that I have disclosed all the details about the study in the terms readily 
understood by the parent 
Date  : Signature  : 
Place : Name         : 
 
CONSENT OF INFORMANT  
I have been informed to my satisfaction, by the attending physician, the purpose of 
the clinical trial, and the nature of drug treatment and follow up including the 
laboratory investigations to be performed to monitor and safeguard my Son / 
Daughter body functions.    
I am aware of my right to opt out to tail at any time during the course of the trial 
without having to give the reasons for doing so. 
        I am exercising my free power of choice, here by give my consent to be 
included as a subject in the clinical trial of “BalakabahariMathirai” for the 
treatment of SooliKanam (Childhood Asthma). 
 
Date   :  Informant Signature   :  
Place  :  Patient Name             :  
Signature of 
witness : 
 Informant Name  :  
Relationship  :  
 
 GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI 
PG DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
PROFORMA OF CASE SHEET FOR SOOLI KANAM 
 
 
IP. No. :  Religion :  
Bed No. :  Parents occupation :  
Name  :  Income :  
Age  :  Date of admission :  
Sex :  Date of discharge :  
Address  :  Diagnosis  :  
Informant :  Medical officer  :  
      
      
1. Complaints and duration  :  
2. History of present illness :  
3. History of past illness  :  
4. Antenatal history  :  
5. Birth history  :  
6. Neonatal history  :  
7. Developmental history  :  
8. Nutritional history   :  
9. Immunization history  :  
10. Family history :  
11. Allergy and contact history  :  
12. Socio economic status :  
GENERAL EXAMINATION 
1. Level of consciousness  :  
2. Nutritional status  :  
3. Posture / Attitude  :  
4. Dysmorphic features  :  
 5. Signs and respiratory distress :  
6. Anemia :  
7. Cyanosis  :  
8. Jaundice  :  
9. Clubbing :  
10. Koilonychias :  
11. Lymphadenopathy  :  
Anthropometry    
1. Height  :  
2. Weight :  
3. Head circumstances  :  
4. Mid arm circumstance  :  
Vital sign    
1. Temperature  :  
2. Pulse rate :  
3. Respiratory rate  :  
4. Heart rate  :  
5. Blood pressure  :  
SIDDHA ASPECTS    
Nilam   
1. Kurinnji :  
2. Mullai :  
3. Marutham :  
4. Neithal :  
5. Paalai :  
Paruvakaalam   
1. Kaar :  
2. Koothir :  
3. Munpani :  
4. Pinpani :  
5. Elavenil :  
 6. Muthuvenil :  
Poripulangal   
1. Mei  :  
2. Vaai :  
3. Kan :  
4. Mooku :  
5. Sevi :  
Kanmenthiriyam   
1. Kai  :  
2. Kaal :  
3. Vaai :  
4. Eruvai :  
5. Karuvai :  
Uyirthathukkal   
Vadham   
1. Praaanan :  
2. Abaanan :  
3. Viyaanan :  
4. Uthaanan :  
5. Samaanan :  
6. Naagan :  
7. Koorman :  
8. Kirukaran :  
9. Devathathan :  
10. Dhananjeyan :  
Pitham   
1. Analpitham :  
2. Ranjagam :  
3. Saadhagam :  
4. Praasagam :  
5. Aalossagam :  
 Kabam   
1. Avalambagam :  
2. Kilethagam :  
3. Pothagam :  
4. Tharpagam :  
5. Santhigam :  
UdalKattugal   
1. Saaram :  
2. Senneer :  
3. Oonn :  
4. Kozhuppu :  
5. Enbu :  
6. Moolai :  
7. Sukkilam / Suronitham :  
Envagaithervugal   
1. Naadi :  
2. Sparisam :  
3. Naa :  
4. Niram :  
5. Mozhi :  
6. Vizhi :  
7. Malam :  
8. Moothiram :  
MODERN ASPECTS    
Respiratory system    
1. Inspection  :  
2. Palpation  :  
3. Percussion  :  
4. Auscultation  :  
Examination of other system     
1. Cardiovascular system :  
 2. Gastrointestinal system :  
3. Central nervous system  :  
4. Excretory system  :  
5. Musculoskeletal system   
Laboratory investigation      
Blood       
1. TC :  
2. DC :  
3. ESR (1 hr) :  
4. Hb % :  
Urine       
1. Albumin  :  
2. Sugar  :  
3. Deposits  :  
Stools    
1. Ova  :  
2. Cyst  :  
Others    
1. X ray chest  :  
2. Other investigation  :  
3. Summary of the case :  
4. Differential diagnosis  :  
5. Diagnosis :  
6. Treatment  :  
7. Prognosis  :  
8. Prevention  :  
 
  
 GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI 
PG DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
ADMISSION DISCHARGE CASE SHEET  
 
 
IP. No. :  Religion :  
Bed No. :  Parents occupation :  
Name  :  Income :  
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